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ABSTRACT 
Cancer metastasis is the critical event leading to 90% of cancer related death. 
Although significant improvement in our understanding on cancer metastasis has 
been made through years of research, the fundamental mechanism behind this 
process is still not fully elucidated. For cancer researchers, the “gold standard” 
for metastasis studies has traditionally been the use of tissue culture and mouse 
models. Tissue culture offers the simplest system and ease of control but is not 
able to recapitulate many of the features found in an in vivo tumor 
microenvironment. On the other hand, mouse model systems offer the most 
sophisticated and physiologically relevant platforms for studying cancer. 
However, the lack of control over the in vivo environment in these mouse models 
and inherent discrepancies from human physiology make results from these 
models difficult to be translated to clinical trials. 
 
The advancement in microfabrication techniques and cancer models developed 
based on these techniques has shown potential in addressing the gap between 
in vitro tissue culture and mouse models. Microscopic tumor microenvironments 
could be built in these in vitro systems to study behavior of human cancer cells. 
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However, the expertise involved in and extra instrumentation needed for 
implementing these systems have prevented their widespread use by general 
cancer researchers. 
 
In this dissertation, we developed two simple microfabricated systems and 
demonstrated their application in two aspects of cancer research. The first 
system is a microfabricated cell patterning stencil, where paracrine signaling can 
be established and its impact can be measured based on cell migration.  Using 
this tool, we investigated the interaction between melanoma and 
microenvironmental cells from their common metastasis target organ. Through 
these simple patterning techniques, we observed significant effects that a given 
microenvironmental cell line had on the two different melanoma lines, as well as 
how melanoma affected different microenvironmental cell lines. The second 
system, a microfluidic device, is able to present individual soluble factors to 
cancer cells in order to test the response of cancer cells to these physiologically 
relevant factors. Through this stand-alone system, we found that breast cancer 
metastasis is influenced by the protein molecules secreted by themselves as well 
as the local glucose level. 
 
Through these findings we believe that our microfabricated systems can benefit 
the general cancer research community in which a complicated problem can be 
broken down into manageable pieces and studied on a simple platform in a 
viii 
 
controlled way. Observation made through these systems can inspire general 
cancer researchers to form new hypotheses and eventually lead to new findings. 
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Chapter 1 Introduction and Thesis Aims 
 
1.1 Brief Introduction on Cancer Metastasis 
Cancer is the second leading cause of death in the United States1; 90% of these 
cancer-related deaths are due to cancer metastasis2, the spread of cancer cells 
from its primary site or organ to another site in the body and a hallmark of cancer 
progression. Despite the conceptualization of metastasis dating back as early as 
the 1800’s, our understanding of cancer metastasis is still quite limited, and the 
mechanism behind this complex process has yet to be elucidated. Although 
metastasis is observed in both patients with liquid tumors and solid tumors, the 
scope of this dissertation will focus on solid tumors. It is now generally accepted 
that cancer metastasis is a multistep process that takes place through the 
lymphatic system or the blood circulation.3, 4 As shown in Figure 1.1, cancer 
metastasis begins as a small group of cells with unregulated growth at the 
primary site. As the cancer progresses, some cancer cells gain invasive potential 
so that they breach the basement membrane. Sometimes, they crawl through the 
blood vessel walls to gain access to the bloodstream, a process called 
intravasation. Most of these cancer cells entering the bloodstream cannot survive 
due to high shear stresses and immune responses.5 A very small fraction of 
circulating cancer cells will re-attach to the inner wall of blood vessel and crawl 
out into tissue, a process called extravasation. These cancer cells dwell in their 
new environment and form micrometastases. Although some micrometastases 
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can stay dormant for years,6 the micrometastasis may also adapt itself quickly to 
the new environment and develop into macrometastases, a phenomenon known 
as colonization. A macrometastasis is more fatal than the primary tumor because 
it is more invasive7 than its progenitor, more widely distributed, and may even be 
drug-resistant8. With the number of steps that must be successfully completed, it 
is clear that cancer metastasis is a very inefficient process: a large number of 
cancer cells may intravasate into the patient’s bloodstream but only a few can 
eventually extravasate into organs, among which a much smaller number of 
cancer cells lead to detectable metastases.9 However, even if just one cell 
succeeds in metastasizing, the consequences could be devastating. 
 
Figure 1.1: Steps in Cancer Metastasis through the blood circulation 
 
1.2 Metastasis Tropism 
Once cancer cells gain access to the bloodstream, they are distributed 
throughout the body. In theory, the probability of forming micrometastases in any 
specific part of the body should be equal. However, equal susceptibility of 
secondary sites has not been observed clinically; instead, specific cancers 
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exhibit preferential metastasis to particular organs. For example, both prostate 
and breast cancers tend to develop bone metastases.10, 11 This type of targeted 
metastasis is called tropism, a phenomenon that has intrigued many physicians 
and researchers for centuries, but the mechanisms underlining which are still 
unknown. One prevailing hypothesis, pioneered by James Ewing, is that 
metastatic tropism is a result of the anatomic structure of the vasculature. For 
example, colon cancer preferentially develops liver metastases12, and this can 
partially explained by fact that the portal vein drains blood from the 
gastrointestinal tract into the liver, increasing the frequency of exposure of colon 
cancer cells to liver tissue13. Thus the metastasis from colon to liver could be 
explained by the anatomy or the “frequency factor”, but this hypothesis cannot 
account for the development of metastases between more distant organs that 
occurs in breast cancer preference for bone metastases. When the primary 
cancer cells leave breast tissue, the first capillary bed they encounter is the 
pulmonary system. However, breast cancer cells do not frequently develop lung 
metastases. This leads to the conclusion that the “affinity” of breast cancer cells 
to the bone environment likely contributes to breast cancer cells’ preferential 
metastasis to the bone. 
 
1.3 Tumor Microenvironment 
In the previous section, we discussed the contributing factors to cancer 
metastasis tropism, “frequency” and “affinity”. In either case, cancer cells leaving 
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the primary sites must extravasate out of the capillary bed and colonize their 
“new home”. The metastatic site offers new challenges for the tumor as it differs 
from the original environment where the cancer cells first develop. Indeed, the 
bidirectional communication between metastatic cancer cells and their new 
microenvironment in the target organ is crucial for cancer survival and outgrowth. 
 
The cellular components of the tumor microenvironment include proliferating 
tumor cells, extracellular matrix, blood vessels, tumor-associated fibroblasts, 
infiltrating inflammatory cells, and a variety of associated tissue cells. 
 
The extracellular matrix (ECM) provides structural support to which cancer cells 
can attach and infiltrate after extravasation. Although the ECM provides some 
extent of inhibition on tumor initiation, it drives tumor progression in later stages 
of the disease.14 ECM in different organs exhibits great diversity in terms of the 
type and amount of matrix macromolecules and the way in which they are 
organized, rendering ECM from each organ unique.15 For example, bone matrix 
consists mostly of collagen I and osteopontin, while brain ECM consists of 
abundant laminin, fibronectin, collagen IV, and proteoglycans.16 Organ-specific 
ECM composition may partially account for metastatic tropism.17 The specific 
ECM composition renders the microenvironment advantageous or 
disadvantageous for metastatic cells with various surface proteins (integrin) and 
proteases (MMP) when attaching or infiltrating, respectively. To complicate 
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matters further, the ECM within the tumor microenvironment is dynamically 
remodeled by the tumor cells to further facilitate tumorigenesis as the tumor 
progresses to more advanced stages. In turn, changes in ECM properties can be 
used as a predictor for clinical prognosis. For example, in breast cancer, a tumor 
can be classified into four subclasses strictly based on ECM composition, which 
correlate well to predict patient outcomes.18 
 
In addition to interacting with the secondary site ECM, tumor cells also interact 
with the native cells, influencing the fate of the metastatic cells in the secondary 
organ. For example, endothelial cells exhibit organ-specific phenotypes 
expressing different endothelial cell adhesion molecules19 that may contribute to 
preferred lodging of tumor cells20 when they flow through the capillary bed and 
facilitate extravasation.21 Furthermore, quantitative differences such as the 
number and avidity of membrane receptor molecules are prevalent among 
endothelial cells from different organs.20 Cancer-associated fibroblasts (CAF), 
abundant in the tumor microenvironment, are thought to promote tumorigenesis 
by depositing distinctly aligned ECM22, secreting cancer survival signaling 
molecules23, 24, and eliciting angiogenesis25. This phenomenon was observed in a 
mouse model where breast cancer cells co-injected with CAF developed 
metastasis more effectively than cancer cells alone. 
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Bidirectional Cellular Signaling 
Soluble signals secreted by both cancer cells and stromal cells in the 
microenvironment can direct cancer metastasis. While circulating in the 
bloodstream and extravasating, cancer cells can sense the chemoattractant 
secreted by the target organ through the vessel wall. These soluble signals direct 
morphogenesis, upregulation of secreted proteases, and infiltration into the 
secondary organ. For instance, breast cancer cells express high levels of CXCR4 
and CCR7 receptors, which mediate actin polymerization and pseudopod 
formation that contribute to chemotaxis and invasion.26 Interestingly, bone 
marrow stroma produces stromal cell-derived factor (SDF-1, also known as 
CXCL12), the ligand for CXCR4.27 Thus it is speculated that this 
CXCR4/CXCL12 axis is responsible for the bone tropism of breast cancer.27, 28 
After tumor cells infiltrate into the parenchyma of a new organ and are 
surrounded by CAFs, the cancer receives survival signals such as TGF-β, SDF-
1, to evade the immune system and adapt to the new microenvironment.29 
Conditioned media of CAF harvested from the liver microenvironment of colon 
cancer metastasis stimulated colon cancer cell proliferation. 30 However, 
conditioned media of normal skin fibroblasts did not exhibit such the same 
mitogenic effect.30 These data demonstrated how specific soluble signals from 
the tumor microenvironment influence the target of cancer metastasis. 
Signaling molecules secreted by cancer cells also constantly modulate the 
behavior of both neighboring and distal cells. Through the secretion of IL-1, FGF-
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2, and PDGF, several carcinoma cell lines have been shown to induce HGF 
secretion from fibroblasts.31 In the context of lung metastasis, primary tumor cells 
secrete VEGF-A, TGF-β, and tumor necrosis factor-α (TNF-α), which induce the 
expression of inflammatory chemokines, S100A8 and S100A9, from both lung 
endothelial and myeloid cells in distant pre-metastatic lung tissue.32 This 
communication between the primary tumor and pre-metastatic niche potentiates 
the success of metastasis.  
 
Other Factors 
Other biochemical factors can drive the progression of cancer cells at the 
secondary as well as the primary site, such as the availability of nutrients and the 
local pH environment. Glucose is one of the most important nutrient sources 
utilized by cancer cells to sustain their abnormally active metabolism. High 
expression of glucose transporter (GLUT-1) in breast cancer cells has been 
shown to correlate with increased in vitro and in situ tumor invasiveness.33 The 
fact that diabetes is associated with an increased risk of some cancers (liver, 
pancreas, endometrium, colon/rectum, breast, and bladder) further suggests that 
hyperglycemia and glucose signaling may direct tumor progression.34, 35 Cancer 
glucose metabolism also affects the acidity of the microenvironment. Through 
diverting a good portion of glucose to lactate rather than directing it to oxidative 
phosphorylation, the local pH decreases to produce an acidic 
microenvironment.36 This acidic environment is reported to favor cancer invasion 
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and suppress anticancer immune effectors. In addition to high glucose 
consumption and increasing acidity, a hypoxic core may develop in a tumor mass 
due to the mismatch between its overactive metabolism and the inadequate 
vascular perfusion during tumor transition from micrometastases to 
macrometastases.37 The low local oxygen level is counteracted by cancer cells 
through stabilization of HIF-1, which leads to expression of VEGF by cancer and 
subsequent angiogenesis.38 
 
1.4 Traditional Models for Studying Cancer Metastasis 
Since cancer has been identified as a disease of uncontrolled cell proliferation, 
cancer cells themselves have been the focus of research, being treated as the 
root cause of this disease. The simplest and most commonly used tumor models 
are therefore two-dimensional (2D) in vitro platforms, such as cancer cells 
cultured in a tissue culture dish. While such models are easy to generate and 
manipulate, they do not mimic the conditions found in the human body.  
 
In the context of cancer metastasis, 2D in vitro models have been used to assess 
the effects of specific oncogenes, growth factors, ECM, and chemotherapy on 
the behavior of cancer cells. For example, the scratch assay has been used 
extensively to quantify migration of cancer cells in response to growth factors and 
drug substances.39 In a scratch assay, a gap or a “wound” is created by scraping 
across a confluent cell layer, and the cell migration into this gap is monitored over 
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time. Another widely used 2D in vitro model is the Boyden Chamber or Transwell. 
In this type of model, cancer cells are cultured on a porous membrane, which 
separates two compartments with different concentrations of chemoattractants. 
The concentration gradient can be established by adding chemoattractants or by 
growing another cell-type in the other compartment. Responding to the 
concentration gradient, cancer cells migrate through the membrane pores, and 
the number of cells on the other side of the membrane is quantified to evaluate 
the potency of the chemoattractant. Additional modifications to this assay may 
better mimic the tumor microenvironment, such as coating the porous membrane 
with ECM molecules or growing a monolayer of endothelial cells prior to seeding 
the cancer cells.40  
 
Due to their simplicity and ease of use, 2D in vitro models are still very popular. 
Indeed, many discoveries made through these models have helped us to 
understand the biology of cancer. However, these models tend to oversimplify the 
tumor microenvironment by isolating the cancer cells from the rest of its native 
environment. As a result, some of the findings using these simplified models are 
not physiologically relevant and may represent an artifact of the model. 
 
Animal models, especially mouse models, have also been widely used to study 
cancer and metastasis. The use of animal models in cancer research can be 
roughly classified into two categories. In the first category, tumors are introduced 
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into the animal by injecting cancer cells harvested from humans (xenogeneic) or 
animals of the same species (syngeneic).41 In the second category, animals 
develop a tumor through chemical induction or genetic engineering.42 Animal 
models provide a very physiologically relevant tumor microenvironment most 
similar to the human body. Through animal models, our understanding of the 
molecular and genetic drivers for cancer metastasis has significantly expanded. 
Genes that mediate breast cancer metastasis to the lung have been identified by 
comparing the microarray signature of the highly and weakly lung-metastatic cell 
populations, which were established through in vivo selection in a mouse 
model.43 The use of a genetically engineered mouse model with inducible 
oncogenic transgenes Myc and K-ras made it possible to observe dissemination 
of mammary cells with unactivated oncogenes to the lung at the very early 
stages of breast cancer development.44 However, animal models still have their 
limitations. First, researchers have little control over the microenvironment once 
the cancer cells are administered to the animal. Due to the sophistication of the 
model, it is also very difficult to evaluate the impact of each variable on the 
progression of cancer. As a result, they are often treated as a black box, i.e. only 
the inputs and outputs are accessible to researchers. Second, human anatomy 
and physiology can differ significantly from that of a mouse. Thus findings in mice 
are not always directly translatable to human disease. In fact, only 8% of findings 
in animal models have been successfully translated to clinical trials.45 Third, 
human cancer usually takes years to develop before it manifests clinical 
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symptoms. In contrast, tumors artificially induced in animal models develop 
quickly, which may limit the clinical relevance of these models. Fourth, variation 
in individual animals and animal handling necessitates a large number of animals 
for statistical significance. Performing animal experiments with large groups of 
animals, together with their high maintenance requirements, becomes 
increasingly costly and labor-intensive. Therefore models that combine the 
simplicity of the in vitro culture and maintain essential elements of the complex 
microenvironment offered by the in vivo models could bridge the large gap 
between the two types of tumor models. Emerging engineered cancer models 
have attempted to address this gap. 
 
1.5 Emerging Cancer Models Based on Microfabricated Systems 
Recent advances in microfabrication technology and biomaterials have aided the 
development of a number of new cancer models engineered to recapitulate the in 
vivo microenvironment in vitro. Microfabrication technology, originally developed 
by the semiconductor industry, has enabled the creation of microscopic 
structures on the order of nano- to micro- meters. Miniaturized patterns that 
mimic the architecture of the microenvironment can be created on a silicon wafer 
through photolithography and/or etching. The silicon wafer can be used directly 
for cancer research or be used as a mold to transfer these patterns onto other 
biocompatible materials such as polydimethylsiloxane (PDMS). Patterned PDMS 
substrates differ from the silicon wafer mold in their stiffness, gas permeability, 
12 
 
 
surface chemistry, and transparency.46, 47 These characteristics of PDMS make it 
suitable for cell culture and observation by light microscopy. PDMS substrates 
can also be bonded together or to other substrates such as glass to create 
microfluidic channels, the scale of which mimic many microscopic structures of 
the human anatomy such as capillaries or lymphatic networks. In addition, 
microfluidic channels can be engineered to manipulate cells to form cell patterns 
that recapitulate the heterotypic cellular interactions that commonly exist within 
the body. 
 
Advancements in biomaterials have enabled the investigation of how particular 
ECM components can affect the metastatic processes. Purified ECM can be 
patterned onto a substrate where seeded cells can sense the pattern of the ECM 
and respond to it by changing their migration behavior.48 ECM molecules can 
also be mixed in prescribed combinations, where each combination may mimic 
the ECM composition of a particular organ.16 Additionally, ECM such as collagen 
and fibrin can be fabricated into 3D gels to model the 3D structure of native 
tissues, which sometimes produces different results from 2D structures due to its 
dimensions.49 
 
Combining microfabrication and novel biomaterials, sophisticated systems have 
been designed to represent the microenvironments involved in each stage of 
cancer metastasis, thus breaking down a complex process into manageable 
13 
 
 
pieces. With these novel microfabricated systems, events that are difficult to 
observe and investigate in vivo can now be studied in vitro. 
 
A great body of research has focused on microfluidic systems for study 
intravasation and extravasation steps. 
  
Zervantonakis et al. created a tumor-vascular interface in a microfluidic device to 
study cancer intravasation.50 In their device, an endothelial monolayer was 
formed along the collagen gel, where cancer cells were encapsulated with or 
without macrophages. Using this setup they could study the transmigration of 
cancer cells through the endothelial layer. When the endothelial layer was 
exposed to TNF-α or macrophages in the ECM gel, more cancer cells breached 
the endothelial layer. Blocking soluble TNF-α in the device normalized endothelial 
layer integrity and decreased the cancer intravasation rate. They therefore 
concluded that TNF-α secreted by macrophages regulated cancer intravasation. 
 
Jeon et al. designed a microfluidic device for studying cancer extravasation using 
an endothelial tube surrounded by a collagen gel that mimics the extracellular 
matrix.51 After seeding cancer cells within the endothelial tube, transmigration of 
cancer cells through the endothelial layer into the collagen gel can be observed 
in real-time. They found that most of the extravasation occurs within the first 24 
hours, and cancer cells disrupt the integrity of the endothelial layer to facilitate 
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transmigration. If desired, the incorporation of organ-specific cells could add 
another layer of complexity to the extravasation model. The same group also 
created a tri-culture adding primary human bone marrow-derived mesenchymal 
stem cells (hBM-MSCs) and osteo-differentiated primary hBM-MSCs, which were 
perfused into the microvasculature formed through vasculogenesis of the 
endothelial cells.52 With this model, breast cancer cells with bone-seeking 
potential were introduced and exhibited an increased extravasation rate 
compared to a muscle-specific model based on C2C12 myoblasts. This model 
also showed that flow shear stress on the microvasculature elicited 
morphological changes, increased vessel permeability and the distance travelled 
by extravasated cancer cells, but reduced the total number of extravasating cells. 
 
Other steps involved in cancer metastasis, such as angiogenesis, have also 
been studied through microfabricated systems. Kim et al. fabricated a perfusable 
microvasculature network in a microfluidic device by seeding endothelial cells 
along one side of a fibrin gel.53 The endothelial cells migrated into the fibrin gel 
and formed microvasculature by sensing cellular signals from the other side of 
the fibrin gel. By seeding cancer cells on the opposite side of the fibrin, they 
could observe how cancer cells impact angiogenesis. 
 
With the advancement of these microfabricated models, our understanding of 
each step in cancer metastasis has been significantly improved by virtue of finely 
controlled conditions, ease of microscopic observation, and in situ testing. These 
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models are also versatile as they can be used in many other applications such as 
a testing platform for antitumor drugs. 
 
1.6 Proposed Cancer Models 
The emerging cancer models based on microfabricated systems have 
demonstrated their power in modeling in vivo microenvironment. However, these 
systems still have not reached their full potential because many general cancer 
labs have not adopted these models. A major barrier lies in the complexity in 
using these systems as well as the additional facilities need to operate these 
systems. To recreate the in vivo microenvironment in vitro, multiple biomaterials 
and cell-types must be introduced into the microfabricated systems sequentially 
or in parallel. This process presents a challenge for researchers without previous 
training in microfluidics. Instruments such as the syringe pump that is used for 
generating flow and a microscope incubator that enables live cell imaging are not 
commodities in a general cancer research lab. These two barriers make it difficult 
for the emerging microfabricated cancer models to be used in general cancer 
research labs. 
 
The motivation of this thesis was to develop simple microfabricated systems to 
study metastatic tropism that are easy to operate and demonstrate its unique 
potential in studying cancer metastasis with controlled microenvironmental 
cellular and soluble factors. A researcher without previous experience in 
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microfluidics would be able to use this simple microfluidic model in his/her own 
research. 
 
1.7 Specific Aims 
This thesis consists of two specifics aims that focus on the cellular signals as well 
as chemical signals and their impact on cancer cell migration. To explore these 
two categories of signals, two microfabricated systems have been specifically 
designed and used for these investigations. 
 
Aim 1: Develop a simple microfabricated cell patterning device to study the 
interaction between cancer cells and organ specific microenvironmental cells. 
For this aim, we have a) designed and fabricated a patterning device and 
validate its cell patterning function and b) used clinically relevant cancer cells and 
organ microenvironmental cells to study the interaction between cancer and its 
target organ. 
 
Aim 2: Develop a microfluidic device to investigate the effect of chemical gradient 
of a chemoattractant molecule on cancer cell migration. For this aim, we have a) 
designed and fabricated a microfluidic device that can present a chemical 
gradient to cells, b) validated the function of this device using known cancer 
cell/chemoattractant pairs, and c) investigated the impact of glucose 
concentration, pH, and other factors on cancer cell migration. 
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The findings reported in thesis were made possible through these 
microfabricated systems, and they have provided insight into the important role 
that soluble factors play in cancer metastasis. Ultimately, the development of 
these tools could benefit a general cancer researcher and provide them with 
tools that are easy to use while retaining the functionality for studying complex 
cell-cell and cell-soluble factor interactions. 
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Chapter 2 Cancer Cells and Microenvironmental Cells Interaction Studied 
Through a Simple Microfabricated Platform 
2.1 Introduction 
Cancer is the second leading cause of death in the United States; notably, 
cancer metastasis accounts for approximately 90% of cancer-related deaths.2 
Although early detection and improved targeted therapies have improved patient 
survival rates for most primary cancers54, the survival rate for metastatic cancers 
remains very poor. For cancer cells to successfully metastasize, they must 
intravasate into the blood/lymph circulation, survive in the vasculature, 
extravasate out of the circulation, and colonize a new organ. Studies with various 
cancer models have led to numerous groundbreaking findings that explain how 
cancer progresses from a neoplasm to a deadly disease.55 Among these findings 
are driver mutations and oncogenes56 that unleash cancer cell proliferation, 
angiogenic switches57 that enable tumors to increase in size, and cancer stem 
cells58 that fuel cancer recurrence following treatment.  
 
Although studies have been fruitful in defining critical pathways associated with 
tumor development and progression, researchers are recognizing that 
microenvironmental cells—non-cancerous cells integrated in the tumor—also 
contribute to the survival and growth of metastatic tumors. Cells within the tumor 
microenvironment may include endothelial cells,59 fibroblasts,59, 60 and immune 
cells,59 along with tissue-specific parenchymal cells. Cancer cells that 
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extravasate out of circulation must adapt to a very different microenvironment 
from that of the primary tumor. Indeed, surviving and growing in a new hostile 
microenvironment is undoubtedly an important and potentially rate-limiting step in 
the progression from a lone cancer cell to macrometastases.61 Proposed by 
Stephen Paget in 1889, the “seed and soil” hypothesis has become one of the 
prevailing hypotheses attempting to explain how cancer metastasizes to a 
secondary site. Specifically, Paget hypothesized that macrometastases develop 
where cells within the secondary site provide a suitable “soil” for cancer survival. 
Subsequent studies have provided evidence to support this hypothesis. 
Nakagawa et al. showed that cancer-associated fibroblasts (CAFs) produce more 
growth factors and molecules that govern cell-cell interactions with cancer cells 
and wound healing than normal skin fibroblasts, thus supporting colon cancer 
growth in liver.30 Similarly, Tabaries et al. found that hepatocytes provide an 
adhesion bed for breast cancer cells by expressing a high level of claudin-2, a 
tissue-specific tight junction component normally found in liver that turned out to 
be crucial for breast cancer cells to seed and colonize the liver.62  
 
These observations underscore the essential influence of microenvironmental 
cells on whether a primary cancer cell is able to form a secondary metastatic 
malignancy. Accordingly, researchers have been using well-established as well 
as new methods to study cancer-microenvironmental cell interactions in vivo and 
in vitro. Mouse models are among the most widely used in vivo models for 
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cancer research, and although they provide a physiologically relevant 
microenvironment for cancer cells, it is not feasible to precisely control 
microenvironmental cells in live mice. Additionally, the complex 
microenvironmental composition in mice makes it challenging to determine 
causal factors in cancer-microenvironmental cell interactions. Furthermore, 
although human cancer cells can be embedded in genetically modified mice, the 
microenvironmental cell is still of mouse origin, which may alter the relevance of 
such systems to human disease.  
 
Recreating cancer-microenvironmental cell interactions in vitro can overcome the 
complications from studying microenvironmental effects in vivo, as specific 
human cell lines can be used to represent both cancerous and 
microenvironmental cells in a controlled setting. A common example is the 
Boyden chamber or Transwell system that uses two physically distinct 
compartments connected by a porous membrane to study cell paracrine effects, 
allowing secreted factors from microenvironmental cells to diffuse to cancer cells 
and vice-versa. In these systems, cancer cell migration across the membrane 
can easily be measured to quantify cancer cell response to soluble factors 
secreted by microenvironmental cells. For instance, Rhodes et al. used the 
Transwell system to show that human mesenchymal stem cells stimulate 
migration of MCF-7 breast cancer cells.63 However, interactions between the two 
cell types within the Transwell are exclusively of soluble form. Also in this type of 
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study, because the two cell types are grown on two different substrates (i.e., 
polystyrene for the bottom well and polycarbonate or polyester for the 
membrane), additional variables, such as substrate stiffness and chemical 
composition, must be considered during data interpretation.  
 
Recent advances in microfabrication and biomaterials enable more controlled 
studies to be carried out.  Microfabricated stencils and stamps allow researchers 
to deposit different types of cells and extracellular matrices (ECM) according to 
pre-defined patterns and can thus establish cell-cell interactions to a resolution of 
100 μm. For example, Dickinson et al. created a series of finely controlled 
cancer-endothelial interactions with microcontact printing, taking advantage of 
preferential adhesion of endothelial colony-forming cells to fibronectin and of 
breast cancer cells to hyaluronic acid.64 More recently, Shen et al. used high 
resolution analysis of similar micropatterned tumor-microenvironmental co-
culture experiments to demonstrate that the proximity of microenvironmental cells 
can have a strong influence on the growth rate, gene expression profile, and drug 
response of a given cancer cell.65 
 
In this study, we used a simple engineered platform to investigate cancer-
microenvironmental cell interactions between melanoma cells and lung epithelial 
cells, hepatocytes, or skin fibroblasts. Melanoma is a very aggressive form of 
skin cancer, for which skin, liver, and lung are common target organs for 
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metastasis.66 We investigated the microenvironmental interactions of two 
different melanoma cell lines, 1205Lu and WM852. 1205Lu is a metastatic 
melanoma cell line experimentally developed from a cell line (WM793) 
established from a vertical growth phase (VGP) melanoma lesion.  After the 
lesion is trypsinized, the resulting cell suspension is subcutaneously injected into 
a mouse, and the 1205 Lu line is generated from a subsequent spontaneous lung 
metastasis. It is a highly invasive and highly migratory cell line.67, 68 WM852 is a 
less aggressive metastatic melanoma cell line originally isolated from a VGP 
stage III (as classified by American Joint Committee on Cancer) metastatic skin 
lesion excised from a patient.69 To establish cancer-microenvironmental cell 
interactions, we used a microfabricated polydimethylsiloxane (PDMS) stencil to 
pattern cancer and microenvironmental cells with a 500 μm gap on tissue culture 
polystyrene. After patterning, both cancer and microenvironmental cells can 
freely migrate into the gap, and the short distance between cells allows paracrine 
communication. Despite its simplicity, the engineered platform revealed important 
differences in the interaction of the two metastatic melanoma cell lines with 
microenvironmental cells. Significantly, our platform identified phenotypic 
differences between the two melanoma lines that may potentially reflect the state 
of tumor progression. 
 
2.2 Materials and Methods 
The stencils for cell patterning (Figure 2.1) were fabricated using soft lithography. 
23 
 
 
Silicon wafers (University Wafers, Boston, MA) were cleaned with piranha 
solution before use. SU-8 2150 photoresist (Microchem, Westborough, MA) was 
spin-coated onto the wafer to achieve a thickness of approximately 0.7 mm. After 
soft baking, the wafer was exposed to ultraviolet light (UV) through a photomask 
(CAD/Art Service, Bandon, OR) with predefined features. The wafer was then 
hard-baked and developed. Polydimethylsiloxane (PDMS; Sylgard 184, Dow 
Corning, Midland, MI) was mixed at a 10:1 ratio (PDMS base to curing agent), 
degassed, and poured over the patterned wafer. A Teflon sheet was laid over the 
PDMS, and a piece of glass with a 1 kg weight placed on top of the Teflon sheet 
was used to apply even pressure during overnight curing at 80°C to ensure 
PDMS stencils had the same thickness as the features on the wafer. Cured 
PDMS stencils were peeled off the wafer and trimmed to fit a 12-well plate. 
Before use, the PDMS stencils were exposed to UV for 1 hr and gently pressed 
down into a 12-well plate to ensure a tight seal between the stencil and the 
bottom of the plate. 
 
Cell Culture 
1205Lu and WM852 metastatic melanoma cell lines expressing green 
fluorescent protein (GFP) were a generous gift from Dr. Meenhard Herlyn (Wistar 
Institute, Philadelphia, PA). We selected different microenvironmental cells that 
best represented the primary parenchymal cells seen in metastatic tissues. Lung 
epithelial cells line the surface of the respiratory tree, making them good 
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candidates for modeling lung tissue. Hepatocytes are the major constituent of the 
liver, accounting for 67% of all cells in liver.70 Skin fibroblasts are the major type 
of cells in the dermis, where melanoma skin metastasis usually occurs. BEAS-2B 
(human bronchial epithelial) cells and BJ fibroblasts (foreskin) were purchased 
from ATCC (Manassas, VA). Immortalized human fetal hepatocytes were a 
generous gift from Dr. Mark Zern from University of California, Davis. All cells 
were cultured in high glucose Dulbecco’s Modified Eagle Medium (Life 
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum 
(FBS; GE Healthcare, Logan, UT), 5 μg/L insulin (Sigma-Aldrich, St. Louis, MO), 
2.4 mg/L hydrocortisone (Sigma-Aldrich), and 2 mM L-glutamine (Life 
Technologies) at 37°C and 5% CO2. We found that we needed to supplement 
basal media with hydrocortisone and insulin to maintain liver cells – the most 
difficult cell type to maintain. Fortunately, we found that this media was able to 
support all the other cell types, and this became the common media used for all 
experiments.  
 
Cancer-Microenvironmental Cell Interaction Assay 
Two days prior to conducting the assay, all microenvironmental cells were treated 
with mitomycin C-supplemented culture media for 24 hr, with mitomycin C 
concentrations for lung, liver, and skin cells at 0.5, 1, and 5μg/ml, respectively, to 
arrest their proliferation (mitomycin C titration data not shown). 
Microenvironmental cell proliferation was arrested to mimic the naturally low 
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proliferative state of these cells in vivo.71, 72 After treatment, cells were washed 
with phosphate buffered saline (PBS) and kept in culture media for another 24 hr. 
The wells of the PDMS stencils were filled flush to the air-liquid interface with 26 
μL of fibronectin (10 μg/ml) and incubated at 37°C and 5% CO2 for 1 hr to 
facilitate cell attachment. The volume was critical to minimize meniscus 
formation, which resulted in uneven seeding. The wells were then rinsed twice 
with PBS. All microenvironmental cells were stained with CellTracker Orange 
(Life Technologies, Carlsbad, CA) according to manufacturer’s protocol before 
trypsinizing. Cells were seeded into the wells of the PDMS stencil at capacity (26 
μL) and incubated at 37°C and 5% CO2 for 3 hr to allow for cell attachment. 
Hepatocytes, lung epithelial cells, and foreskin fibroblasts were seeded at a 
density of 1.2×106 cells/ml to form a confluent monolayer upon cell attachment. 
1205Lu and WM852 were seeded in full culture medium at 0.6×106 cells/ml, 
which ensured that they did not become overconfluent as they continued to 
proliferate over the course of the experiment. The stencils were then peeled off, 
and each well was rinsed with warm PBS and filled with culture media 
supplemented with 1% FBS. Immediately after, the plate was imaged using an 
Axiovert S100 microscope (Zeiss, Germany) equipped with a MAC2002 
motorized stage (Ludl Electronic Products, Hawthorne, NY). A motorized stage 
was used to take images at the specified coordinates of the 500 μm gaps of each 
cell combination, once at 0 hr and again at 72 hr. The plate was maintained at 
37°C and 5% CO2 for the 72-hr period between imaging. 
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Data Analysis and Significance Testing 
Images for each fluorescent marker (GFP and CellTracker Orange) were merged 
using ImageJ, and the merged pictures at 0 h and 72 hr are stacked together. A 
box with 500 μm width was drawn on the 0 hr picture to fit the gap, and the 
position of the box was transferred to the 72 hr picture to mark the cell migratory 
front. The areas covered by both cancerous and microenvironmental cells in the 
gap were obtained. The number of cancer cells within the 500 μm gap was 
counted manually.  
 
We quantified the alignment of microenvironmental cells relative to the cancer 
patterning front within the gap using a two-dimensional fast Fourier transform (2D 
FFT) method73. Briefly, 2D FFT was performed on microenvironmental cells 
within the gap to convert spatial information about cell orientation into frequency 
information. The resulting FFT yielded oval spectra for angles from 0° to 360°. 
Radial sums over this oval were calculated using the ImageJ (NIH) “Oval profile” 
plug-in with a sampling frequency of 12°, which yielded a π-periodic plot of the 
overall orientation angle of the cells. Data from 0°–180° was added to that from 
180°–360° as 2D FFT is symmetric about 180°. All angles were shifted by 90° 
so that 180° represents an orientation that is perpendicular to the cancer cell 
patterning front. The data was then normalized such that the total sum was unity. 
Cells with random orientation would have a uniform angle distribution, with a 
value of 0.0667. 
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The overlap between cancer and microenvironmental cells was defined by the 
horizontal distance measured between the furthest migrating cells into the 
opposing population of cells at 72 hr. 
 
Each cell combination was performed in triplicate. Analysis of variance (ANOVA), 
followed by the Tukey-Kramer multiple comparison post hoc testing, was used to 
determine if the area covered by cancerous and microenvironmental cells within 
the gap was significant and if the difference in cell orientation of 
microenvironmental cells was significant, t-tests were used to determine if the 
cancer-microenvironmental cell overlap was significant. A p-value <0.05 was 
considered to be significant. Statistics were analyzed using PRISM (Graphpad, 
La Jolla, CA). 
 
2.3 Results 
Establishing Cancer-Microenvironmental Cell Interaction 
A microfabricated PDMS stencil (Figure 2.1) was used to segregate cancer from 
microenvironmental cells on the surface of tissue culture plastic. As shown in 
Figure 2.2, the stencil leaves straight and clear boundaries with a 500 μm gap 
between cancer cells (left side) and microenvironmental cells (right side). The 
500 μm gap size was chosen based on diffusion distance of chemokines, 
migration speed of cancer and microenvironmental cells, and ease of maintaining 
a good seal between PDMS and tissue culture plastic. Melanoma cells have 
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been reported to migrate as fast as 20 μm/hr74, and normal tissue cells have 
migration speeds on the same order of magnitude,75, 76 suggesting closure of the 
500 μm gap can be achieved within 72 hr. As the effective intercellular 
communication distance has been estimated to be around 250 μm for individual 
cells,77 and the separation between cell types decreases as cells cover the gap, it 
is reasonable to assume that cancer-microenvironmental cell chemokine 
communication occurs at this separation distance. Unfortunately gaps narrower 
than 500 μm were not possible to test in this system because the PDMS stencils 
were not able to seal against the tissue culture plastic surface, leading to mixing 
of the two cell types during seeding.  
 
Influence of Microenvironmental Cells on Cancer Cells 
1205Lu is a highly invasive and highly migratory metastatic melanoma cell line 
originally derived from a stage IV metastatic lesion.67, 68 To examine the 
interaction of 1205Lu cells with different types of microenvironmental cells, they 
were cultured opposite lung epithelial cells, hepatocytes, or skin fibroblasts, and 
images were taken of the gap and the areas on either side of the gap after 72 hr. 
A higher percentage of 1205Lu melanoma cells occupied the gap when co-
cultured with lung epithelial cells or skin fibroblasts compared to when co-
cultured with hepatocytes (Figure 2.3 and Figure 2.4). When co-cultured with 
lung and skin, 1205Lu melanoma cells moved a significantly greater distance 
(p=0.0058) beyond their original patterning boundary than in the absence of 
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opposing microenvironmental cells (Figure 2.4A). A number of 1205Lu cells were 
also observed beyond the initial boundaries of these microenvironmental cells, 
confirming the high degree of invasiveness of this cell line. In contrast, 
hepatocytes had no apparent effect on 1205Lu cell movement. Coverage area 
and cell densities were not significantly different than values observed in the 
absence of microenvironmental cells (Figure 2.4A) and (Figure 2.4E), and this is 
reflected in a roughly equal distribution of 1205Lu cells and hepatocytes within 
the gap (Figure 2.3A). 1205Lu coverage was decreased with 1205Lu cells on the 
opposing side. Since 1205Lu cells covered more than half of the gap area when 
alone, patterning them on opposing side impeded its coverage when cell-cell 
contact happened. (Figure 2.10)  
 
WM852 melanoma cells responded very differently to the three types of 
microenvironmental cells than 1205Lu. WM852 was isolated from a localized 
stage III metastatic lesion in the skin of the patient69, and the cell migration 
results showed that it is not nearly as invasive as 1205Lu (Figure 2.4). Although 
all three microenvironmental cell lines have a slight tendency to increase WM852 
movement into the area between the patterning boundaries, this trend was not 
significantly different (p=0.3392) than the movement observed in the absence of 
microenvironmental cells. Consistent with the absence of a cytokinetic effect, 
none of the microenvironmental cells had an effect on WM852 cell number. 
Accordingly, WM852 cells accounted for a much lower percentage of cells 
moving into the area between the patterning boundaries than for 1205Lu cells 
30 
 
 
when incubated with a given type of microenvironmental cell. Culturing WM852 
cells on opposing sides did not affect their coverage in the gap. Since WM852 
cells alone covered less than half of the gap area, cell/cell contact did not happen 
when they were cultured on opposing sides. (Figure 2.10) 
 
We observed that migration of melanoma cells on the opposite side of the cancer 
pattern, the side that is not next to microenvironmental cells, was similar to that 
of melanoma cells alone. (Figure 2.11) 
 
We confirmed that the advance of melanoma cells into the gap was due to both 
proliferation and migration. Ki67 staining showed that 40–60% of melanoma cells 
within the gap were proliferating. (Figure 2.8) 
 
We treated microenvironmental cells with mitomycin C to mimic their stationary 
feature in vivo. To confirm this was necessary for observing cancer-
microenvironmental cell interactions, another set of experiments was done 
without mitomycin C treatment. Unleashing proliferation of microenvironmental 
cells changed their migration pattern as well as the subsequent influence on 
cancer cell migration. (Figure 2.9) All microenvironmental cells proliferated and 
migrated into the gap significantly over the 72 hour period. 1205Lu migration was 
retarded by all microenvironmental cells comparing to the non-mitomycin C 
treated conditions. Specifically, lung epithelium inhibited 1205Lu migration by 
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covering the majority of the gap and as a result, 1205Lu barely migrated beyond 
their patterning boundary. On the other hand, WM852’s migration was mostly 
unchanged. This could be due to the fact that their migration was minimal even 
when the microenvironmental cells were not treated with mitomycin C. 
Interestingly, when co-cultured with skin fibroblasts, WM852’s migration was 
slightly stimulated (p<0.05). This might indicate that the mitomycin C treatment 
changed the paracrine signal secretion of skin fibroblasts. Due to the significant 
advancement of microenvironmental cells into the gap, we focused our analysis 
on mitomycin C-treated conditions, where proliferation of microenvironmental 
cells did not dominate the gap area. 
 
Influence of Cancer Cells on Microenvironmental Cell Migration 
It is evident from Figure 2.2 that, just as microenvironmental cells differentially 
influence cancer cell migration, cancer cells also differentially influence 
microenvironmental cell migration. These data are quantified in Figure 2.5. In the 
absence of cancer cells, all three microenvironmental cell lines migrated into an 
area beyond their initial patterning boundaries, with hepatocytes and lung 
epithelial cells moving further than skin fibroblasts. Addition of 1205Lu cells in co-
culture significantly increased the area occupied by hepatocytes, and, 
surprisingly, significantly decreased the area occupied by lung epithelial cells. 
1205Lu cells had no effect on the area occupied by skin fibroblasts. The 
advancing fronts of lung epithelial cells and skin fibroblasts were relatively 
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straight. However, hepatocytes migrated further and displayed a less distinct 
front, resulting in greater interaction with tumor cells. Addition of WM852 cells 
into co-culture gave markedly different results than those observed with 1205Lu 
cells. WM852 cells induced a striking increase in migration distance observed for 
skin fibroblasts (p <0.05); on the other hand, only a slight but non-significant 
increase in the migration distance of hepatocytes and no effects on migration of 
lung epithelial cells were observed. We observed that migration of 
microenvironmental cells on the opposite side of the microenvironmental cell 
pattern, the side that is not next to cancer cells, was similar to that of 
microenvironmental cells alone. (Figure 2.11) 
 
Influence of Cancer Cells on Microenvironmental Cell Orientation 
Close examination of photomicrographs such as those depicted in Figure 2.2 
revealed that WM852 cells induced skin fibroblasts to polarize and become 
elongated along an axis perpendicular to the original WM852 melanoma cell 
front, a finding consistent with directed cell migration. Figure 2.6 depicts results 
of the 2D FFT analysis for the directional distribution of each microenvironmental 
cell line in response to the two cancer lines. Consistent with what can be 
discerned visually, skin fibroblasts showed a striking tendency to orient around 
180o (p<0.05), which is perpendicular to the WM852 patterning front. 
Hepatocytes had a slightly lesser, but still strong tendency to orient towards 
WM852 cells, but only a weak (if any) orientation of lung epithelial cells was 
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observed.  In contrast, 1205Lu cells induced very little cellular reorientation, with 
the exception of a small effect on hepatocytes. Overall, the influence of the two 
cancer lines on the orientation of each type of microenvironmental cell was highly 
consistent with the corresponding influence on microenvironmental cell 
movement beyond the patterning boundary. Together, these results suggest that 
WM852 cells have a strong influence on the directed cell migration of skin 
fibroblasts, and that both WM852 and 1205Lu cells have a smaller directed 
migration effect on hepatocytes. 
 
Cancer and Microenvironmental Cell Overlap 
As successful metastatic tumor growth requires close interaction between tumor 
and microenvironmental cell, we investigated this issue using results obtained 
from our engineered platform. Accordingly, photomicrographs exemplified by 
those in Figure 2.2 were reanalyzed to determine the overlap distance between 
the cancer and microenvironmental cell fronts. This metric puts more weight on 
the fastest moving cell in the population despite how the collective migration 
might be. 1205Lu cells had a larger overlap distance than WM852 cells when co-
cultured with hepatocytes and lung epithelial cells. WM852 cells had a slightly 
larger overlap area than 1205Lu cells when co-cultured with skin fibroblasts, but 
the effect was not significant (Figure 2.7). The large overlap or “level of 
interaction” of 1205Lu co-cultures can be mainly attributed to the high 
“invasiveness” of 1205Lu cells. In contrast the large overlap of WM852 with skin 
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is mainly due to the “receptiveness” of them to each other as both types of cells 
can be found within each other’s original pattern. 
 
2.4 Discussion 
Conducting migration assays using our simple microfabricated stencil offers 
some distinct advantages over traditional scratch assays, including the ability to 
co-culture experiments and cleaner pattern boundaries free of dead or peeling 
cells. These advantages make image analysis and data interpretation more 
straightforward. The 500 μm gap is small enough to allow paracrine signaling as 
well as being captured by microscope in one field of view. While the gap is big 
enough so cells can migrate freely in response to any potential paracrine signals 
before cell/cell contact happens. Our system is also superior to Transwell-type 
assays in that it allows cell-to-cell contact in addition to paracrine interactions 
between cancer and microenvironmental cells, thereby more closely 
approximating interactions in vivo. Although the gap is not coated by ECM by the 
time the stencil is peeled off, the ECM contained in the common media will 
gradually be adsorbed, providing a consistent ECM coating for all cell 
combinations. Finally, the effects of microenvironmental cells on cancer cells as 
well as the effects of cancer cells on microenvironmental cells can be evaluated 
simultaneously.   
 
This study has two underlying hypotheses. First, independent of 
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microenvironmental influences, not all metastatic tumors are alike. Second, the 
microenvironmental tissue surrounding a tumor provides essentially an in vivo 
selection process, and any cell lines derived from such a tumor may be 
predisposed to interact more strongly with microenvironmental cell lines derived 
from the site of origin of the parent cell line. The 1205Lu and WM852 melanoma 
cell lines are appropriate for this comparative study because 1) although they are 
both metastatic melanoma cell lines, they are derived from tumors taken at 
different stages of cancer development (distant metastasis in a mouse xenograft 
system versus primary metastatic lesion from a patient, respectively), and 2) the 
parent tumors are derived from different metastatic sites (lung and skin, 
respectively). By showing differences in the inherent mobility of the two cancer 
lines and their corresponding response patterns to microenvironmental cells 
derived from three different tissues, our results support both hypotheses.   
 
Our mobility assay showed that 1205Lu cells migrate significantly further than 
WM 852 cells in the absence of microenvironmental cells, achieving a migratory 
front of at least 250 μm into the 500 μm gap. It is widely accepted that high cell 
motility correlates with high metastatic potential.78 It should be noted, however, 
that 1205Lu and WM852 are isolated from different patients and subject to 
different isolation protocols; hence any firm conclusions regarding the 
relationship between cancer stages are impossible. Lung epithelial cells and skin 
fibroblasts both promoted an even greater 1205Lu migration beyond their 
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patterning boundaries, and with lung epithelial cells, this increased motility is 
associated with an increase in number of cells migrating into the gap, which may 
be expected to result from directed cell migration. Although these observations 
would be consistent with the hypothesis that selecting a spontaneous lung 
metastasis to create the 1205Lu line selects for cancer cells that respond 
positively to paracrine communication from lung epithelial cells, far more 
comprehensive testing with different cell lines derived from lung and other tissues 
is required to obtain a definitive conclusion. What we can conclude, however, is 
that the 1205Lu cell line clearly responds differently to different 
microenvironmental cell lines. In contrast, WM852 cells are less migratory, and 
their mobility seems to be unaffected by any of the microenvironmental cell lines 
tested in our study. WM852 cell also require a longer time to attach to tissue 
culture plastic than 1205Lu. Interestingly, it appears as though there are two sub-
populations of WM852 cells: a small population that migrates well into the 
microenvironmental-patterned area, and a much larger population that migrates 
very little. It is possible that the cells that migrate into microenvironmental-
patterned areas are indicative of a sub-population of tumor cells obtained from 
the original tumor tissues versus an adaptive response of tumor cells that was 
acquired in vitro, which would be consistent with finding of a heterogeneity in 
DNA mutations and therefore within the same tumor.79  
 
Whereas the 1205Lu line is more motile and responsive to microenvironmental 
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cell influences than the WM852 line, the WM852 line appears to have a greater 
influence on microenvironmental cells. When cultured next to WM852, all three 
microenvironmental cell lines became more migratory and occupied most of the 
500 μm gap. In particular, skin fibroblasts and hepatocytes displayed strong 
directed migration towards WM852 cells (Figure 2.2 and Figure 2.6), including 
the appearance of an elongated phenotype where the elongational axis is 
directed toward the WM852 cells. Given that WM852 cells are derived from skin 
metastasis, the observation that they elicit the greatest directed migration effect 
on skin fibroblasts is not surprising. The most important result gleaned from the 
data in Figure 2.6, however, lies in the comparison of the weakly migratory/high 
migration-promoting phenotype of WM852 cells with the highly migratory/weak 
migration-promoting phenotype 1205Lu of cells and in the implications this 
dichotomy has on the mechanisms by which cancer cells and 
microenvironmental cells interact to form a tumor. In essence, 1205Lu migration 
is stimulated by co-culture with certain types of microenvironmental cells, and in 
those situations they aggressively move toward and even into the 
microenvironmental cells. WM852 are less mobile, and their mobility was not 
significantly affected when co-cultured with the same types of 
microenvironmental cells, but they actively recruited microenvironmental cells in 
a cell-type (and potentially tissue-) selective manner, possibly through paracrine 
signals they secrete. If representative of the parent tumor behavior in vivo, these 
observations have potentially significant clinical ramifications. While both 
38 
 
 
mechanisms would allow for the eventual development of tumor structure (the 3D 
arrangement of cancer cells and microenvironmental cells), the mechanism by 
which the tumor is constructed would be very different, and it would be 
reasonable to speculate that different therapeutic regimens would be required for 
treatment.    
 
Future studies focused on identification of paracrine factors from 
microenvironmental cells that stimulate 1205Lu migration as well as those from 
WM852 that attract microenvironmental cells could prove useful in elucidating 
targetable chemokine signaling pathways for each class of tumor cells. For 
example, TGFβ80, interferon-α81, and IL-682 are potential growth factors secreted 
by fibroblasts that can modulate melanoma behaviors. Ultimately, “brute force” 
high-throughput pharmacological testing could also be carried out using our 
simple assay to identify drugs with potential to block these paracrine factors. 
 
Finally, it should be noted that the microenvironmental cells used in this study 
represent only a small fraction of organ-specific cells. Testing other organ-specific 
cells may help identify the key type of cells in each organ that interact with 
tumors. Cell lines are easy to obtain and use, but cells from patients with known 
cancer diagnosis and prognosis would be of more clinical value, and our simple 
microfabricated platform could easily be adapted to conduct this type of study. 
The current 2D platform could also potentially be modified into a 3D platform to 
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better mimic the 3D microenvironment in living tissue64, 83 and hence improve its 
predictive capabilities. 
 
2.5 Conclusion 
In this study, we report a simple microfabricated stencil to pattern different 
melanoma and microenvironmental cell types in close vicinity. Although bi-
directional migratory effects were seen between microenvironmental cells and 
both melanoma lines, the nature of these effects differs. 1205Lu metastatic 
melanoma cells exhibited a highly migratory pattern and became even more 
migratory in the presence of specific microenvironmental cell types in co-culture 
experiments. The high motility of 1205Lu correlated with the fact that they 
develop into lung metastasis in mouse model. In the opposite direction, 1205Lu 
melanoma cells enhanced hepatocyte migration, had no effect on skin fibroblast 
migration, and slightly inhibited lung epithelial cell migration. Our findings also 
revealed that WM852 metastatic melanoma adapts an entirely different pattern 
that is much less motile than 1205Lu; it does, however, actively recruit skin 
fibroblasts and hepatocytes but does not affect the movement of lung epithelial 
cells. The highly directed migration of skin fibroblasts towards WM852 cells 
correlated well with the origin of WM852, a skin metastatic lesion from a human 
patient. Thus, our simple engineered system allows for unique observations of 
tumor-microenvironmental communication networks that are expected to provide 
critical insights into tumor-specific behaviors. Such communication networks 
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appear to be associated with specific metastatic phenotypes and could be 
targeted through the development of novel therapeutic strategies for cancer. 
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Figure 2.1: Microfabricated stencil to pattern cancer and microenvironmental 
cells. A PDMS Stencil was laid onto tissue culture plastic and pressed gently to 
ensure a tight seal. Cancer and microenvironmental cells with appropriate 
density were added to either well. Cells were allowed to attach to tissue culture 
plastic for 3 hr before the stencil was removed, leaving patterned cell islands 
behind. The gap between the two cell islands is 500 μm. 
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Figure 2.2: Interaction between metastatic melanomas and different 
microenvironmental cells. (A) Melanoma cells (green), 1205Lu and WM852 were 
patterned next to lung epithelial cells, skin fibroblasts and hepatocytes with a 500 
μm gap at 0 hr. After 72 hr, 1205Lu cells occupied the majority of the gap except 
when they were cultured with hepatocytes. On the other hand, 
microenvironmental cells occupied the majority of the gap when they were co-
cultured with WM852. In addition, skin fibroblasts showed strong directed cell 
migration toward the cancer cells. (B) Magnified picture of 1205Lu with 
hepatocytes at 72 hr and of WM852 with skin fibroblasts at 72 hr.  
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Figure 2.3: Percentage of gap area covered by melanoma cells. (A) 1205Lu cells 
constituted over 80% of the cells within the gap when cultured with lung epithelial 
cells and skin fibroblasts, but only about 40% when cultured with hepatocytes. 
1205Lu distributions under lung and skin co-culture were significantly different 
from that under liver co-culture but not different from each other. (B) WM852 cells 
constituted less than 40% of the cells within the gap. For each type of melanoma 
cell, the distribution measurement was compared among three co-culture 
conditions, using one-way ANOVA followed by multiple comparison. “*” indicates 
a p<0.05. 
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Figure 2.4: Melanoma coverage and cell number within the 500 μm gap. (A) and 
(B) 1205Lu cells covered more area within the gap when co-cultured with lung 
epithelium cells and skin fibroblasts than when cultured alone. WM852 cell 
migration was not significantly affected when co-cultured with 
microenvironmental cells. (C) and (D) Number of cancer cells present within the 
gap after 72 hr. More 1205Lu cells migrated into the gap when co-cultured with 
microenvironmental cells than mono-culture. No difference was observed for 
WM852 cells.  For each type of melanoma, measurement obtained through co-
culture was compared to that obtained through cancer mono-culture, using one-
way ANOVA followed by multiple comparison testing. 
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Figure 2.5: Coverage of microenvironmental cells when co-cultured with 
melanoma cells. Hepatocytes covered more area in the gap, while lung 
epithelium covered less of the gap area when co-cultured with 1205Lu than 
alone. Skin fibroblasts covered more of the gap area when co-cultured with 
WM852 than alone. For each type of microenvironmental cell, coverage under 
the influence of 1205Lu and WM852 was compared with that when 
microenvironmental cells were cultured alone, using one-way ANOVA followed by 
multiple comparison testing.  
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Figure 2.6: Microenvironmental cell orientation quantified by 2D FFT. (A) and (B) 
Orientation peaks of all WM852 and skin fibroblasts co-culture experiments were 
located around 180° indicating that WM852 cells oriented toward cancer cells. 
Skin fibroblasts co-cultured with 1205Lu displayed no obvious peak orientation. 
(C) and (D) Hepatocytes showed alignment toward both WM852 and 1205Lu 
cells, with less pronounced alignment toward 1205Lu. (E) and (F) Lung 
epithelium showed no alignment toward either melanoma cell line as indicated by 
flat orientation distribution curves. Alignments for three independent experiments 
were plotted for each condition. The baseline for orientation observed in control 
experiments conducted in the absence of melanoma cells is 0.0667. 
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Figure 2.7: The overlap between cancer and microenvironmental cells. The 
overlap was defined as the horizontal distance between the furthest migrating 
cells of either cancer or microenvironmental population towards the other 
population. After 72 hr, co-culture with 1205 Lu showed more overlap than co-
culture with WM852; however, WM852 and 1205Lu co-cultured with skin 
fibroblasts showed similar amounts of overlap. For each type of 
microenvironmental cell, t-test was performed to compare the influence of 
1205Lu and WM852 on overlap. 
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Figure 2.8: Ki67 staining of melanoma cells. A) Representative image showing 
that cell nucleus were stained by Hoechst stain. B) Representative image 
showing that melanoma cells were stained by Ki67 primary antibody and 
fluorescently labeled secondary antibody. Celltracker Orange dye labelling 
microenvironmental cells also appeared in the same image. Yellow line indicates 
the boundary between melanoma and microenvironmental cells. C) 40–60% of 
melanoma cells were proliferating. The ratio of proliferating WM852 cells were 
higher when co-cultured with hepatocytes than other co-culture conditions.  
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Figure 2.9: Non-mitomycin C treated microenvironmental cells altered cancer-
microenvironmental interaction. (A) Coverage of 1205Lu cells was inhibited by 
liver, lung and skin cells patterned on the opposing side. (B) Coverage of WM852 
cell was not affected by microenvironmental cells except coverage was 
stimulated by co-culturing with skin fibroblasts. (C) Microenvironmental cells 
showed significant coverage into the 500 μm gap. Hepatocytes coverage was 
inhibited by WM852. Lung epithelial cells covered the majority of the gap area. 
Skin fibroblasts coverage was inhibited by both types of melanoma cells. 
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Figure 2.10: 1205Lu cell coverage within the gap was inhibited while co-culturing 
with themselves on the opposing side. WM852 cell coverage within the gap was 
not affected when co-culture with themselves on the opposing side. 
 
 
Figure 2.11: A) Cancer cell coverage and B) Microenvironmental cell coverage on 
the side that was opposite to the one interfacing with the other type of cells was 
similar to monoculture. 
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Chapter 3 Microfluidic Transwell to Study Cancer Cell Migration 
In the previous chapter, microfabricated stencils were used for observing the 
paracrine communication between cancer cells and microenvironmental cells on 
the cellular level. In this chapter, we sought to develop a microfluidic device to 
present individual soluble factors to cancer cells so that chemotaxis of cancer 
cells to each factor could be measured independently. 
 
3.1 Introduction 
Chemotaxis, the migration of an organism or cell in response to a chemical 
stimulus, plays a central role in a wide range of biological phenomena from 
embryogenesis to cancer metastasis. In embryogenesis, chemotactic gradients 
direct fibroblast migration and extracellular matrix production84, promote 
relocation of neuronal precursors to the cortical plate from the ventricular 
region85, and orchestrate the precise morphogenetic movement of cells to form 
tissue structure86. In the immune response, neutrophils chase after invading 
bacteria87, leukocytes migrate towards a site of injury88, and immature plasma 
cells emigrate from the spleen to bone marrow89. During cancer progression, 
chemotactic migration results in recruitment of tumor-associated macrophages90, 
angiogenesis91, and metastasis towards tumor-specific target tissues92. All these 
chemotactic events occur through sensing molecular gradients. Given the 
importance of chemotaxis in these biological processes, researchers have 
sought to better understand mechanisms to provide insights on the complex cell-
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cell communication networks in normal and diseased states. 
 
Chemotaxis has been studied extensively in vitro by using multichamber 
platforms where the chambers are separated by a porous membrane. These 
chambers allow the researcher to create simple chemical gradients that are 
easily controlled and do not have the confounding variables of in vivo systems. 
Transwell, a commercialized product, is widely used by biomedical scientists in 
all fields to study chemotaxis in vitro, including those studying cancer metastasis. 
For example, researchers have used Transwell assays to show cancer cell 
migration towards chemokines such as EGF93 and SDF-194, contributing to our 
knowledge of the molecular driving forces governing tumor cell motility and 
invasiveness.  
 
A Transwell consists of a multi-well plate and small inserts having thin porous 
membranes at the base. To conduct a Transwell assay, a cell suspension is 
added into the inserts, and media containing chemoattractants is added to the 
(bottom) wells in the plate. The inserts are placed in the plate wells, and the two 
are incubated together for a defined amount of time, during which some cells 
migrate from the top-side of the membrane to its underside through pores in the 
membrane. After incubation, the inserts are removed from the multi-well plate, 
washed, fixed and stained. Before imaging the fixed inserts, Q-tips or cotton 
swabs are used to wipe the top-side of the membrane gently to remove cells that 
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have not migrated, leaving migrated cells untouched. Multiple regions of each 
insert are imaged, and the numbers of cells in each image are averaged to 
estimate cell migration for that insert. 
 
The simplicity of the Transwell makes it an excellent tool for chemotaxis studies 
for a broad range of biomedical researchers with various technical backgrounds. 
However, Transwell migration assays have numerous limitations. First, the 
washing and staining steps will wash off loosely attached cells, resulting in 
underestimation of both migrated/non-migrated cells. Second, each membrane 
needs to be wiped with a Q-tip to remove the non-migrated cells, during which 
the force applied on the Q-tip needs to be carefully controlled. Wiping with too 
much force may break the membrane, while wiping too gently does not 
adequately remove all cells that have not migrated, leading to overestimation of 
the number of migrated cells. Furthermore, cells near the edge of the membrane 
are always more difficult to wipe off due to limited accessibility. Third, due to the 
manufacturing process of the insert membrane, the membrane pores are neither 
homogeneous nor evenly distributed. (Figure 3.6) This heterogeneity in “paths” 
for cell migration results in significant variation. Fourth, cell seeding densities on 
the membrane is often uneven,95 likely caused by the meniscus around the edge 
of the inserts. Together, these deficiencies all lead to significant variability when 
measuring chemotactic behavior of the cells. The Transwell assay also has 
limitations associated with timing. For example, the gradient established by 
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Transwell is a transient step gradient as only a thin porous membrane separates 
media with and without chemoattractant. As diffusion of chemoattractant through 
thousands of holes on the membrane dissipates this step gradient quickly, the 
assay is most effective when used over shorter time periods, and control 
experiments must be performed to establish the optimal incubation duration for a 
particular cell line/chemoattractant pair. Lastly, the Transwell assay is an 
endpoint assay, which means only a snapshot of the cell migration can be 
observed at the end of the assay. Thus, even if an optimum timing window can 
be established, time-course experiments are inherently variable due to the need 
for multiple Transwells. 
 
Recently, the expanding use of microfluidics in biomedical research has been 
applied to study chemotaxis with superior resolution and repeatability. Due to its 
small size, materials required for each experiment such as cells and 
chemoattractant can be minimized. Moreover, the chemoattractant gradient can 
be controlled with micron-scale resolution. These benefits of microfluidic systems 
have begun to make them an attractive tool for chemotactic studies. Using a 
microfluidic gradient generator, Jeon et al. studied the chemotaxis of neutrophils 
towards both simple and complex interleukin-8 gradients.96 With similar 
techniques, Mosadegh et al. examined the response of MDA-MB-231 breast 
cancer cells towards linear and non-linear gradients of epidermal growth factor 
(EGF).97 More recently, Lin et al. used a sophisticated microfluidic device to 
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delineate the effect of EGF gradient and “contact inhibition of locomotion” on 
breast cancer cell migration at single cell resolution.98 All of these examples 
show the power of microfluidics in studying chemotaxis; however, sophisticated 
microfluidic systems (such as those containing a valve system) usually require 
external instruments (e.g. syringe pumps) and microfluidic expertise for operation 
(e.g. connecting tubing, preventing bubbles, keeping cells viable while imaging). 
This presents a technological barrier for general biomedical research, because 
most researchers lack the specialized equipment and/or expertise. Recognizing 
these limitations, other investigators have designed flow-free microfluidic 
chemotaxis assays, which eliminate the need for external instruments to maintain 
flow.99, 100 However, time-lapse microscopy or other sophisticated imaging 
analysis such as estimating the total length cell traversed is needed for 
quantifying chemotaxis in flow-free systems; thus they are far from an ideal 
solution. In this study, we have developed a simple flow-free microfluidic device 
that can be operated in a similar manner to a Transwell chamber for chemotaxis 
studies, referred to here as the “microfluidic Transwell”. Using the microfluidic 
Transwell, we quantified chemotaxis of MDA-MB-231 1833 breast cancer cells 
towards epidermal growth factor (EGF) and demonstrated that its performance is 
superior to that of a traditional Transwell chamber. The microfluidic Transwell 
presented in this paper offers users greater control over the chemotaxis assay, 
reducing the chance of user-dependent errors and facilitating quantification. 
Moreover, its simplicity and ease of operation allows it to be adapted in 
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biomedical labs of varying expertise. 
 
3.2 Materials and Methods 
Microfluidic Transwell Fabrication 
The novel microfluidic Transwell (Figure 3.1) developed here consists of a glass 
bottom layer, 2 layers of plasma-bonded polydimethylsiloxane (PDMS) with one 
“cell-chamber layer” and one “inlet-outlet layer”. The cell-chamber layer contains 
five chambers (115 μm high, 600 μm diameter) and wedge-shaped 
microchannels (15 μm high, 200 μm long) connecting these chambers. The inlet-
outlet layer contains larger channels connecting inlet and outlet ports to each of 
the chambers on the cell-chamber layer. The cell-chamber layer has one 
chamber in the center for cell seeding and four outer quadrant counting 
chambers that are each connected to the seeding chamber by wedge-shaped 
microchannels; wedge-shaped channels have been shown to promote uni-
directional cell migration such that the smaller outlet minimizes backwards 
migration.101, 102 Thus, migrating cells exhibit movement only from the central 
seeding chamber towards each of the counting chambers. The inlet-outlet layer 
consists of 5 pairs of inlet and outlet channels that facilitate introduction of media 
into the counting chambers and the cell suspension into the seeding chamber. 
 
The two layers were fabricated using standard soft lithography techniques. 
Briefly, polydimethylsiloxane (PDMS, Dow Corning) was mixed at a 10:1 ratio 
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(base to curing agent), degassed under vacuum, and poured onto SU-8 
(MicroChem, Westborough, MA) micropatterned wafers (University Wafers, 
Boston, MA), which were prepared by photolithography. To create the cell-
chamber layer, the PDMS mixture was poured onto a wafer with a negative 
pattern of the cell-chamber layer and a polystyrene sheet was pressed over the 
PDMS mixture until the plastic touches the pattern on the wafer to create a 115 
μm thick PDMS layer. For the inlet-outlet layer, the PDMS mixture was poured 
onto a wafer with a negative pattern of the inlets and outlet channels, and no 
polystyrene sheet was needed. After curing overnight at 80°C, the PDMS was 
peeled away from the wafer. A piece of glass and the cell-chamber layer were 
treated with air plasma for 45 seconds and then pressed together to bond. Then, 
the polystyrene sheet is easily peeled away from the cell-chamber layer bonded 
to glass. The inlet and outlet holes on the inlet-outlet layer were created with a 
1.2 mm biopsy punch (Harris Uni-Core, Ted Pella, Redding, CA). Both layers 
were then plasma-treated for 45 seconds, aligned under a stereoscope, and 
bonded. The assembled microfluidic Transwell was incubated overnight at 80°C 
to restore hydrophobicity. Before usage in cell studies, the microfluidic Transwell 
was sterilized with 1 hour UV exposure, put under vacuum for 5 minutes to degas 
the PDMS, and incubated at 37 °C and 5% CO2 for 30 minutes. 
 
Cell Culture 
MDA-MD-231 1833 human breast cancer cells (a gift from Dr. Joan Massague at 
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Memorial Sloan Kettering Cancer Center, NY) were cultured in high glucose 
DMEM (Life technologies, Grand Island, NY) supplemented with 10% Hyclone 
FBS (Thermo Scientific, Waltham, MA) and 2mM L-glutamine (Life technologies) 
at 37 °C and 5% CO2. 
 
Seeding the Microfluidic Transwell and Chemokine Stimulation 
Before the experiment, two 200 μL pipette tips (EZ Rack, Denville, Plainfield, NJ) 
per microfluidic Transwell were trimmed at the 10 μL graduation line and 
sterilized by autoclaving. One tip was inserted into the inlet connecting to the 
center chamber. Human fibronectin (EMD Millipore, Billerica, MA) was diluted in 
PBS (phosphate buffered saline) at a concentration of 10 μg/ml, and 4 μL of the 
diluted fibronectin was injected into each of the chambers. The device was then 
incubated at 37 °C and 5% CO2 for 30 minutes. MDA-MD-231 1833 human 
breast cancer cells were trypsinized, neutralized with culture media, and spun 
down by centrifugation at 50 x g for 4 minutes. Cells were then re-suspended in 
culture media at 4 million/ml. A clean pipette tip was inserted into the inlet on the 
opposite side, and the cancer cell suspension was injected gently into the center 
chamber via the inlet. Excess cell suspension was held in the pipette tip. 
Recombinant human epidermal growth factor (EGF, R&D Systems) was diluted in 
DMEM with 0.2% bovine serum albumin (BSA, Sigma-Aldrich) at concentrations 
of 10 ng/ml and 50 ng/ml. BSA-supplemented DMEM with or without EGF or 
culture media were injected into the quadrant chambers. The devices were 
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transferred into 60 mm Petri dishes with drops of PBS over the chambers to 
minimize evaporation through the PDMS during incubation at 37°C in 5% CO2 for 
3 hours. A PDMS sheet with three 3.5 mm-holes and one 17.5 mm-hole punched 
out were placed on top of the microfluidic Transwell (Figure 3.1c) to contain 
media. The 3.5 mm-holes were filled with BSA-supplemented DMEM, while the 
17.5 mm-holes were filled with BSA-supplemented DMEM with different 
concentrations of EGF or culture media. The devices were then incubated for 24 
hours at 37°C in 5% CO2 to allow cell migration through the microchannels. 
 
Staining, Imaging, and Quantification of Cell Migration 
The PDMS sheet with 3.5 mm-holes was removed, and the excess media was 
aspirated. Cells within the devices were fixed with 4% formaldehyde solution in 
PBS for 30 minutes at room temperature. The formaldehyde solution was then 
replaced by 5 μg/ml Hoechst dye (Life Technologies) in PBS for 30 minutes at 
room temperature to stain the cell nuclei. The staining solutions were then 
aspirated and the devices imaged by an epifluorescent microscope (Axiovert 
S100, Zeiss, Germany). Fluorescence images were taken for all quadrant 
counting chambers by a CMOS camera (Princeton Instruments, Acton, MA) using 
a 10X objective, and the number of cells in each was counted using ImageJ. Cell 
migration for each device was quantified by averaging the number of cells 
present in the four quadrant chambers. 
Transwell Experiment 
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Migration of MDA-MB-231 1833 breast cancer cells towards EGF was also 
determined using Costar Transwells with 6.5 mm diameter and 5 μm pores 
(Corning, NY). The membrane in the Transwell insert was coated on both sides 
with 10 μg/ml human plasma fibronectin by incubating for 1 hour at 37 °C and 5% 
CO2. After incubation, the fibronectin solution was aspirated, 100 μl of MDA-MD-
231 1833 breast cancer cells with a total number of 50,000 cells were added into 
the insert. The inserts were then transferred to wells of 24-well plate containing 
650 μl of 0.2% BSA-supplemented DMEM containing 0, 10 and 50 ng/ml EGF. 
After incubation at 37 °C and 5% CO2 for 2, 4, 12, 24 hours, the membranes 
were washed by PBS, fixed by 4% paraformaldehyde solution, and stained with 
Hoechst dye. The membrane was imaged once at the center to confirm 
attachment of cancer cells on the membrane. Then the top-side of the membrane 
was wiped twice with a Q-tip. Each membrane was imaged (10X magnification) 
at 4 random locations. Cell number was determined for each field of view and 
averaged for each membrane. 
 
Statistical Analysis 
All conditions were tested using three different devices (n = 3). Migration data 
was analyzed by one-way ANOVA followed by multiple comparisons using Tukey 
tests in PRISM (Graphpad). Statistical significance was determined at a 
significance level of α <0.05. 
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3.3 Results 
Cell Seeding 
There are two requirements for high-fidelity quantitative cell migration 
measurements using the microfluidic Transwell: cell attachment must be 
restricted to the seeding chamber, and the seeding density in the chamber must 
be consistent. 
 
The ability to restrict cell attachment to the seeding chamber was facilitated by 
the delayed wetting of microchannels that connect seeding to counting 
chambers. During the first few hours of fluid introduction to the seeding and 
counting chambers, microchannels did not contain liquid due to surface tension 
at the entrances to the microchannels, except for small amounts of condensation 
within the microchannel. However, the microchannels started taking up liquid 
within the first 5 hours of fluid introduction because air leaked out of the device 
due to the high gas permeability of PDMS. This phenomenon was observed 
during fibronectin coating and cell seeding. 
 
The confluence of cells within the chamber must also be tightly controlled. There 
are two main challenges of seeding a controlled number of cells into a tiny space 
via microfluidic channels. First, evaporation of media is a significant issue. 
Second, once a cell suspension is injected into the seeding chamber, there 
should be as little flow as possible afterwards to prevent cells from entering or 
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exiting the seeding chamber, which might remove an unknown number of cells. 
Injecting a marginally excess cell suspension forms a liquid bead over the outlet, 
which minimizes media evaporation but causes a slow backflow into the 
chamber. To prevent this problem, we inserted a trimmed pipette tip into the 
outlet prior to cell injection so that excess liquid will be held due to capillary 
forces. As a result, the seeding density will only be affected by the density of cell 
suspension. As shown in Figure 3.2, in six microfluidic devices seeded with MDA-
MB-231 1833 cells, there were on average 218 cells seeded with a standard 
deviation of 7 cells. All cancer cells attached within 3 hours of incubation at 37°C 
in 5% CO2. The capability to observe and quantify cells after seeding is one of 
the advantages offered by the microfluidic Transwell. 
 
Impact of seeding density on cell migration 
Controlling seeding density is important for the operation of the microfluidic 
Transwell, as this variable was shown to significantly affect the proportion of cells 
migrating from the seeding chamber into the counting chambers in the following 
test using FBS as a chemoattractant (Figure 3.3). Seeding densities of MDA-MB-
231 1833 breast cancer cells at 4 million/ml (resulting in about 218 cells seeded) 
produced a confluent monolayer within the seeding chamber, while seeding at 8 
million/ml resulted in an overly confluent cell layer. In the absence of FBS 
chemoattractant, the number of cells that migrated into the counting chamber in 
the control condition at 8 million/ml was 6-fold higher than that at 4 million/ml 
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seeding density (Figure 3.3). Although the addition of an FBS gradient increased 
migration at both seeding densities, the % increase in migration diminished at 
higher seeding density due to the greatly increased baseline migration in the 
control condition. Because high seeding densities reduced the sensitivity of the 
microfluidic Transwell when results are expressed as % of control, we chose 4 
million/ml as the seeding density for the remainder of the study. 
 
MDA-MB-231 1833 showed dose-dependent response to EGF stimulation in 
Microfluidic Transwell 
MDA-MB-231 1833, a highly invasive breast cancer cell subline derived from 
bone metastases in a mouse model11, is a very well-studied model of breast 
cancer metastasis to bone. It has been shown that 1833 retains the epidermal 
growth factor receptor (EGFR) present in its parental cell line, MDA-MB-231, 
which is known to migrate towards EGF gradients.43 This property of the MDA-
MB-231 1833 allowed us to investigate whether our microfluidic Transwell could 
delineate a dose-dependent response of 1833 to EGF.103 Accordingly, we 
quantified migration of cancer cells towards EGF after incubating cancer cells in 
the microfluidic Transwells for 24 hours. As expected from results observed with 
the parental cell line, we observed a dose-dependent response of 1833 to EGF, 
with an average of 3.3, 9.7, and 20.7 cells migrating in response to 0, 10, and 
50ng/ml EGF, respectively. We also compared the response of 1833 to DMEM 
containing 10% FBS, which is commonly used as a chemoattractant for 
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chemotaxis studies. As indicated in Figure 3.4, MDA-MB-231 1833 cells migrated 
in response to 10% FBS at statistically similar rates to those observed with a 
10ng/ml EGF gradient. These results show A) the microfluidic device is able to 
present different EGF gradients to the cells within the seeding chamber, and B) 
MDA-MB-231 1833 breast cancer cells migrate dose-dependently towards EGF 
gradients.  
 
MDA-MB-231 1833 showed response to EGF stimulation in Transwell 
without significant dose dependency 
We next conducted a similar experiment using a traditional Transwells in order to 
compare the results generated with the two platforms. The Transwell experiments 
were allowed to run for different amounts of time to determine the optimal 
experimental duration for measuring MDA-MB-231 1833 cell chemotaxis. Overall, 
the results showed that MDA-MB-231 1833 breast cancer cells displayed a 
chemotactic response towards EGF in the traditional Transwell assay, and that 2 
hour is the optimal duration as it resulted in the most significant fold change 
between EGF and control. The results also showed that the apparent EGF-
dependent chemotactic effect steadily declined thereafter, such that no significant 
effect was observable at 24 hr Figure 3.5. However, the result differed from that 
obtained in the microfluidic Transwells in two aspects. First, migration in 
Transwell in the absence of an EGF gradient was very high, where on average 
97.5 out of 900 cells migrated per field of view after only 2 hours of incubation. 
65 
 
 
Consistent with the fact that it is an ongoing process, this non-specific migration 
increased steadily over time. Second, although 10 ng/ml EGF stimulated cell 
migration, there was no further increase in migration when 1833 cells were 
exposed to a higher EGF concentration (50 ng/ml). It should be noted that 
migration results were based on the number of cells on the underside of the 
membrane according to common practice in Transwell assays.103–105 Cells that 
fell off the membrane were estimated to be less than 5% the total number of cells 
seeded into the insert (data not shown), and thus were not included in the 
migrated cell count. 
 
3.4 Discussion 
In this study, we developed a simple flow-free microfluidic device (microfluidic 
Transwell) that can be operated in a similar manner to a Transwell chamber for 
chemotaxis studies, and subsequently used it to quantified chemotaxis of MDA-
MB-231 1833 breast cancer cells towards epidermal growth factor (EGF). 
Compared to the traditional Transwell, the main advantages of this device are: 1) 
allowing observation of cell migration during the assay instead of only at the end, 
2) minimizing non-specific migration while differentiating response to 
chemoattractant concentration, 3) eliminating steps requiring human 
manipulation that introduce increased variability (e.g. the Q-tip wiping step) and 
offering more consistent quantification of migrated cells, and 4) minimizing 
variability in the size and number of migration channels. 
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 Although a recent improvement of the Transwell assay allows real-time 
monitoring of cell migration106, a significant drawback to this method is its 
requirement for pre-labelling cells with fluorescent dyes and using a plate reader 
that images only the underside side of the porous membrane. In contrast, the 
microfluidic Transwell proposed in this study does not require any additional 
equipment for the operation of migration assay, where cells that migrate through 
the microchannel are collected in the counting chamber and could potentially be 
isolated for further study. Additionally, the techniques required to perform the 
microfluidic Transwell assay, such as pipetting, are similar to those needed for 
the traditional Transwell assay, eliminating the need for specialized training on 
additional equipment or complex laboratory techniques. 
 
Some researchers have also developed an indirect method for quantifying cell 
migration in the traditional Transwell to eliminate the need for manual 
manipulation (Q-tip wiping): the method involves seeding at very high cell 
densities such that the cells migrate through the membrane pores and eventually 
detach, falling into the lower chamber.107 Only a small percentage of the seeded 
cells may migrate and detach, leading to a very small sample size for analysis. 
Furthermore, this method of quantification is based on an unverified assumption 
that the cells detaching and landing in the lower chamber is proportional to the 
number of cells migrating through the membrane. This method may also 
introduce confounding factors due to different types of chemoattractant gradients 
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contributing to the rate and efficiency of detachment that could lead to either 
under- or over-estimates of migration. The microfluidic Transwell eliminates 
manual manipulation with a direct measurement of cell migration that does not 
depend on an additional detachment variable. 
 
We designed wedge-shaped microchannels to promote unidirectional migration 
and minimize retrograde migration. The 100 μm high chambers lead into 15 μm 
microchannels: the narrower microchannels help to slow down the rate of 
diffusion and equilibration of the chemoattractant gradient. Indeed, due to its 
static nature, the gradient established in the device diminishes over time (Figure 
3.7) and is not maintained as well as other microfluidic gradient generators with 
constant flushing96. However, a gradient still exists from ~650–850 nM across the 
microchannel and, based on fluid dynamics simulations, should be acceptably 
maintained between 10 to 24 hours.  The gradient can be even better maintained 
if 1) the chemoattractant of interest has a low diffusion coefficient, 2) the height 
and the diameter of the seeding chamber are enlarged to function as a better 
sink, and 3) the height of the microchannel is further reduced to minimize the 
diffusion of the chemoattractant into the seeding chamber. However, the 
chemotactic data in Figure 3.4 and the calculated gradient duration both indicate 
that even the present microfluidic Transwell design maintains a chemoattractant 
gradient for a significantly longer (~ 24 hr) than the traditional Transwell, which 
loses its gradient within minutes to hours.54 Rapid gradient dissipation 
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undoubtedly explains why the EGF-dependent migration of MDA-MD-231 1833 
cells quickly declines over time such that it is not statistically observable by 4 hr. 
Rapid gradient dissipation also likely contributes to the lack of a significant 
difference in migration towards 10 or 50 ng/ml EGF even though the estimated 
steepness of the starting gradient ranges from 1 ng/(ml*μm) to 5 ng/( ml*μm) 
(calculated from the concentration difference divided by the thickness of the 
membrane). Pursuant to the calculated gradient in the traditional Transwell, it 
should also be noted that results obtained through microfluidic Transwells show 
statistically significant difference in migration when the steepness of the starting 
gradient changes from 0.05 ng/(ml*μm) to 0.25 ng/( ml*μm) (calculated by 
concentration difference divided by the length of the microchannel).  
 
Due to the different cell sizes specific to each cell type, an optimal seeding 
density must be determined for each cell type to be analyzed accurately with the 
microfluidic Transwell. The optimal seeding density should form a confluent layer 
upon initial cell attachment within the seeding chamber. Both overly confluent 
and under-confluent seeding are undesirable, as the “signal” (cell chemotaxic 
migration) to “noise” (non-chemotactic migration) ratio will be affected. Here we 
have demonstrated that increasing seeding density increases the extent of 
migration with all other conditions kept constant. It has been reported that cell 
migration velocity from a confluent layer of cells to an empty space is dependent 
on the local cell density, where cells only start to migrate after a threshold density 
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has been met108, and migration velocity increases as seeding density increases. 
When the seeding chamber is overly confluent, cells near the entrance of the 
microchannel are “pushed” towards the counting chamber due to the high cell 
density behind them. This overcrowding effect causes increased migration in the 
absence of a chemoattractant gradient (i.e. the control condition), with the 
greater value in the denominator, making the response to chemoattractant less 
pronounced when expressed as a percentage of the control value. As a result, 
the signal-to-noise ratio will be compromised. On the other hand, low seeding 
densities are also suboptimal. A COMSOL simulation of the microfluidic device 
Figure 3.7 predicts that only cells close to the entrance of the microchannels 
would be able to sense the gradient. In an under-confluent condition, a random 
walk must occur before cells get close enough to the entrance of the 
microchannel to sense any gradient. The number of cells migrating into the 
counting chamber is thus limited by the number of cells close enough to the 
entrance to sense the chemoattractant gradient. As a result, having few cells 
immediately next to the microchannels will reduce the “signal” and will increase 
the time required to observe quantifiable migration. 
 
In summary, we developed a microfluidic device for this study and used it to 
study cell migration in response to a chemoattractant gradient created by 
dissolved FBS and EGF. The microfluidic device can also be used to evaluate 
chemoattractant gradients released by other cell types in co-culture experiments 
70 
 
 
where cells are cultured within the counting chamber. For these experiments, cell 
migration can be stimulated by soluble chemoattractant factors secreted by the 
cells seeded in the counting chamber, and cells migrating into the counting 
chamber would also be subjected to cell-cell interactions.  
 
3.5 Conclusion 
We demonstrate a microfluidic Transwell that offers simplicity, consistency and 
ease for quantifying cell migration. With this system, we determined the optimal 
seeding conditions for MDA-MD-231 1833 breast cancer cells. Furthermore, we 
observe dose-dependent migration of MDA-MD-231 1833 breast cancer cells 
towards EGF. The migration data obtained through the microfluidic Transwell 
shows much lower non-specific migration but higher resolution in a dose-
dependent response to EGF than those obtained in traditional Transwell. The 
microfluidic Transwell will aid researchers with different backgrounds and 
contribute to the advancement of chemotaxis research. 
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Figure 3.1: Design of the microfluidic Transwell. (A) The microfluidic Transwell 
consists of two layers of PDMS. The top layer consists of five pairs of holes 
which are connected to the five pairs of cell channels on the underside side of 
the top layer. The bottom layer, which is depicted with greater detail in panel B, 
consists of five chambers, which are overlaid by the five pairs of cell channels on 
the top layer. (B) The five chambers connect to each other via wedge-shaped 
microchannels. The chambers are 115 micron high and 600 micron wide, while 
the microchannels are 15 micron high and 200 micron long. C) A fully assembled 
microfluidic Transwell made from PDMS. The holes on the top layer shown in 
panel A are overlaid by PDMS walls, which are used to contain media with or 
without chemoattractant.  
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Cell seeding in 6 different microfluidic Transwells. After 3 hours, cells 
seeded within the seeding chamber attached to the fibronectin-coated substrate. 
With a seeding density of 4 million cells/ml, on average 218 cells attached in the 
seeding chamber with a standard deviation of 7 cells. 
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Figure 3.3: Seeding density affects number of cells migrating into the counting 
chamber with all other variables kept constant. Under the same seeding density, 
10% FBS increased cell migration resulting in a greater number of cells in the 
counting chamber (p < 0.05). However, increasing seeding density from 4 million 
cells/ml to 8 million cells/ml also increased the cell migration in the control 
condition when no chemoattractant was present. For optimal baseline control, 
seeding density was kept at 4 million cells/ml for all further experiments. 
  
73 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Representative image of migrated cells within the counting chamber. 
Cells were fixed and stained with Hoechst dye. Yellow lines represent the 
boundaries of microchannels and counting chambers. (A) MDA-MB-231 1833 
cells migrated into the counting chamber with DMEM supplemented with 0.2% 
BSA (control), which represents a baseline for non-chemotactic migration. (B) 
MDA-MB-231 1833 cells migrated into the counting chamber with 50ng/ml EGF. 
(C)MDA-MB-231 1833 cells showed dose response to EGF in microfluidic 
Transwell. “*” indicates migration statistically different from control, and “**” 
indicates migration statistically different from control and “*”. 
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Figure 3.5: MDA-MB-231 1833 migration assay using Transwell. A) MDA-MB-231 
1833 cells attached to the membrane under 0 ng/ml EGF before Q-tip wiping. B) 
After Q-tip wiping, the cancer cells that migrated through the membrane under 0 
ng/ml EGF remained on the membrane. C) MDA-MB-231 1833 cells showed 
response towards EGF after incubation between 2 hours and 12 hours. But their 
migration under different EGF concentration was not clearly differentiated. “*” 
indicates migration that is statistically different from the control. No difference in 
migration was observed at 24 hour. 
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Figure 3.6: Pore distribution of a Costar 6.5 mm polycarbonate Transwell insert 
with 8 μm diameter pores. A) 158 pores were found on one field-of-view of the 
membrane. Arrow heads: two pores are coalescing, forming a pore bigger than 8 
μm. B) 103 pores were found on another location of the same membrane. C) The 
average of number of pores on 9 fields of the same membrane indicating an 
average of 132 ± 17 pores. Scale bar is 50 μm.  
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Figure 3.7: Diffusion of EGF simulated in COMSOL Multiphysics software with a 
diffusion coefficient set at 10-6 cm2/s. The distribution of EGF at 0h, 10h and 24h 
is shown in panels A,B and C respectively. The range of colors in the legend 
represents concentrations of 0 to 10-6 M. D) Profiles of EGF concentration across 
the microchannel at 0 h (blue), 1 h (green), 2 h (red) and 24 h (cyan). 
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Chapter 4 Delineate Soluble Factors that Inhibit Cancer Cell Migration 
through a Microfluidic Transwell 
In the previous chapter, we discussed the development of a microfluidic 
Transwell to present chemoattractants to cancer cells and quantify the response 
of cancer cells to the chemoattractant gradient through simple counting. This 
demonstrated the proof-of-concept functionality of the device. In this chapter we 
explore the applicability of this device by investigating how cancer cell migration 
is affected by various soluble cues. 
 
4.1 Introduction 
Tumors are known to be abnormally metabolic active; to sustain their 
uncontrolled growth, cancer cells have very high nutrient demands and in turn 
secrete a very high level of metabolic waste. For normal cells, diffusion of 
nutrients and waste across the capillary wall is sufficient to keep everything in 
balance. However, the extra demands for nutrient and metabolic waste 
transportation in tumors cannot be supported due to the lack of vascularization in 
very small lesions, such as micrometastases. In progression to colonization in 
the secondary site, tumor cells are constantly seeking nutrients and space to 
support their uncontrolled growth. Tumors are commonly referred to as spheroids 
when they are small in size and composed of heterogeneous cells types, 
including cancer cells, cancer-associated fibroblasts, and immune cells. Cancer 
cells on the outer layer of the spheroid are exposed to the host 
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microenvironment, consisting of the host cells and ECM, and often migrate away 
from the spheroid, although migration towards the spheroid core has also been 
reported. To determine their direction of migration, these outer cells must take 
into account all the cues presented in the microenvironment from both the host 
and the cells within the spheroid. Soluble factors and their gradients could be 
potential factors that dictate migration direction. For example, cancer cells inside 
the spheroid constantly produce soluble factors such as metabolic waste and 
other paracrine signals in addition to consuming nutrients. 
 
In this study, we used the microfluidic Transwell developed in the previous 
chapter to explore whether cancer cell migration is affected by neighboring 
cancer cells, pH, and glucose. We also attempted to determine the potential 
paracrine factors secreted by cancer cells themselves that can impact the cancer 
cell migration. 
 
4.2 Materials and Methods 
Cell Culture 
MDA-MD-231 1833 human breast cancer cells (a gift from Dr. Joan Massague at 
Memorial Sloan Kettering Cancer Center, NY) were cultured in high glucose 
DMEM (Life technologies, Grand Island, NY) supplemented with 10% Hyclone 
FBS (Thermo Scientific, Waltham, MA) and 2mM L-glutamine (Life technologies) 
at 37 °C and 5% CO2. 
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Microfluidic Transwell Fabrication and Preparation 
The microfluidic Transwells were fabricated and sterilized according to methods 
described in Chapter 3. At the beginning of each experiment, the microfluidic 
Transwells were coated with 10 μg/ml human fibronectin, incubated at 37 °C and 
5% CO2 for 30 minutes to promote cell adhesion upon cell seeding. 
 
Cancer-Cancer Co-Culture in Microfluidic Transwell 
MDA-MD-231 1833 cells were harvested and resuspended in culture media at a 
cell density of 4X106 cells per ml. Cell suspension was injected gently into the 
center chamber and one of the four quadrant chambers. Culture media was 
introduced into the rest of the three quadrant chambers. The devices were 
incubated at 37 °C and 5% CO2 for 3 hours to allow cell attachment. PDMS walls 
with three 3.5 mm-holes and one 17.5 mm-hole punched out were placed on top 
of the microfluidic Transwell (Figure 1c) to contain media. All holes were filled 
with cell culture media. The devices were then incubated for 24 hours at 37°C in 
5% CO2 to allow cell migration through the microchannels. 
 
Cancer Cell Migration with Conditioned Media 
To study whether cancer cell migration was affected by the soluble factors 
secreted by cancer cells themselves, we used conditioned media as a source of 
factors secreted by cancer cells. To prepare conditioned media, cancer cells were 
seeded and cultured in cell culture media in a tissue culture dish until they were 
80 
 
 
80% confluent. The culture media was aspirated and fresh tissue culture media 
or plain DMEM was added to the tissue culture dish. The cells were cultured for 
another 24 hours. The media within the dishes were collected and spun down at 
50g for 5 minutes. The supernatant was then used as the conditioned media with 
FBS or without FBS. MDA-MB-231 1833 cells were seeded only into the center 
chamber and the conditioned media was seeded into the quadrant chamber. 
After 3 hours incubation, the PDMS walls were put on top of the device, the 3.5 
mm holes were filled with culture media and the 17.5 mm hole was filled with 
conditioned media. The devices were incubated for 24 hours. 
 
Cell Migration with Heat Inactivated Conditioned Media 
Heat inactivation is known to denature heat labile proteins. The conditioned 
media contains proteins that are secreted into or modified by the cancer cells. To 
determine if any of these proteins could potentially impact cancer cell migration, 
we used heat inactivation to denature these proteins assuming they were not 
heat stable. Since the serum contained in the media has already been heat 
inactivated by manufacturer, the additional heat inactivation likely denatures 
proteins secreted into the conditioned media. Heat inactivation was carried out by 
heating up the media to 56°C and held for 30 minutes. For the cell migration 
assay, MDA-MB-231 1833 cells were introduced into the center chamber of the 
microfluidic Transwell. The quadrant chambers were filled with heat-inactivated 
conditioned media or conditioned media as control. After putting the PDMS walls 
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on top of the microfluidic device, the 3.5 mm holes were filled with fresh cell 
culture media and the 17.5 mm hole was filled with the same media in the 
quadrant chambers for this device. The devices were then incubated 37 °C and 
5% CO2 for 24 hours. 
 
Characterizing Protein in Conditioned Media 
In an attempt to understand the nature of the factors (s) in the conditioned media 
responsible for inhibiting cancer cell migration, we performed two biochemical 
tests to investigate sulfated-glycosaminoglycan (GAG) and changes in protein 
profile. 
 
For both types of tests, an SDS-PAGE was performed as the first step. Fresh 
media, conditioned media with serum and/or conditioned media without serum 
were mixed with 5X sample buffer (10% w/v SDS, 10 mM dithiothreitol, 20% v/v 
glycerol, 0.2 M Tris-HCl and 0.05% w/v Bromophenolblue) to achieve a final 
concentration of 1X sample buffer. Of note, the fresh media and conditioned 
media with serum originally came from the same bottle of stock media to 
minimize variation in serum composition. Then the media mixture was heated in 
boiling water for 5 minutes to denature the protein. While the mixture was cooling 
down to room temperature, 4–15% precast Criterion gradient protein gels (Bio-
Rad) were loaded onto a Criterion gel electrophoresis cells (Bio-Rad, Hercules, 
CA), the electrophoresis cells were filled with running buffer (25 mM Tris-HCl, 
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200 mM Glycine and 0.1% (w/v) SDS). 10, 20 and 30 μL of denatured media was 
loaded into the wells of the precast gels along with Full-Range Amersham 
Rainbow Marker (GE Healthcare). Then 200 volts was applied to the gel for 
approximately 35 minutes until the protein bands were sufficiently separated. The 
gels were taken out of the cassette gently for further staining. 
 
To determine if the protein within the conditioned media contained sulfated-GAG, 
the gels were co-stained by Coomassie Blue and Dimethylmethylene Blue 
(DMMB), which stained for protein and sulfated-GAG, respectively. 
 
To carry out Coomassie Blue staining, the gel was first stained with 0.1% 
Coomassie Blue R250 in 10% acetic acid, 50% methanol, and 40% H2O for 20 
minutes. Then the staining solution was discarded and replaced with de-stain 
solution (10% acetic acid, 50% methanol, and 40% H2O) with gentle shaking for 
3 hours with at least 3 washing solution changes. Finally, the gel was kept in the 
de-stain solution overnight under gentle shaking. After the Coomassie blue 
background faded away on the gel, it was ready for DMMB staining. The DMMB 
staining solution was prepared by dissolving 16 mg DMMB in 1L H2O containing 
3.04g glycine, 1.6g NaCl and 95 mL of 0.1M acetic acid. The gel with Coomassie 
blue stain was soaked in the DMMB staining solution with gentle shaking for 1 
hour. Then the gel was ready for imaging. 
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The protein profiles of each type of media was visually determined on the gel by 
silver stain because of it higher sensitivity than Coomassie blue stain. Pierce 
Silver Stain Kit (ThermoFisher Scientific) was used to stain the SDS-PAGE gel 
with all three types of media. Manufacture-recommended procedures were 
followed to perform the staining, where the gel was allowed to develop for 2 
minutes.  
 
The gels with Coomassie blue and DMB co-staining and silver stain were imaged 
by Molecular Imager VersaDoc MP 4000. To quantify protein profiles of fresh 
media and conditioned media with serum, picture of the sliver stained gel was 
imported into ImageJ. Rectangular boxes were drawn to include the lanes 
containing each type of media. The protein profiles were plotted by the gel 
analysis plug-in. The profiles for each type of media were then segmented and 
aligned together using major peaks as reference points. The discrepancy 
between the profiles of each type of media was then evaluated. 
 
Cancer Cell Migration with pH Adjusted Culture Media 
Media pH was also investigated as a potential contributing factor on cancer cell 
migration. Cell culture media contains sodium bicarbonate as its buffering 
system. Once in a CO2 – controlled environment, a balance between dissolved 
CO2, HCO3- , and CO32- is established. When the media was incubated in the 
tissue culture incubator with 5% CO2, the pH is about 7.4. To determine the pH of 
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conditioned media with FBS, the conditioned media was equilibrated in the 
incubator with 5% CO2. Then the media was taken out and immediately measure 
by a pH paper. The conditioned media had a pH of 6.8. To mimic the pH of 
conditioned media in fresh culture media, 1 N HCl was added to fresh culture 
media to adjust the pH. A pH of 6.8 was achieved by adding 5 μL 1 N HCl for 
every ml of culture media and a pH of 6 was achieved by adding 10 μL 1 N HCl 
for every ml of culture media. To carry out the migration assay, MDA-MB-231 was 
seeded only into the center chamber and the quadrant chambers were filled with 
pH-adjusted cell culture media. After 3 hours of incubation, PDMS walls were put 
on top of the microfluidic Transwell, where the 3.5 mm holes were filled with cell 
culture media and the 17.5 mm holes were filled with pH-adjusted cell culture 
media or cell culture media as control. 
 
Cancer Cell Migration with Different Glucose Level 
The glucose level is one of the main energy sources in cell culture media. 
Glucose is used in glycolysis and citric acid cycle for energy production. As 
cancer cells grow in the media, glucose will be consumed by cells and as a result 
it concentration will drop. To determine the glucose concentration of the 
conditioned media, we used a blood glucose meter to measure the 
concentration. Since the glucose concentration within high glucose DMEM was 
much higher than the physiological concentration, thus out of the linear reliable 
detection range of the glucose meter, a standard curve for the glucose meter was 
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established by measuring media with known glucose concentration and by 
recording the corresponding reading from the glucose meter. The glucose 
standard solution was prepared by diluting high glucose DMEM (4.5 g/L glucose) 
to a lower concentration by PBS. The data points were fitted by a quadratic 
function for generating the standard curve. Conditioned media made from a dish 
with 60% and 80% confluency was measured by the glucose meter and the 
reading was plug into the function for the standard curve and the actual glucose 
concentration was solved. To prepare cell culture media with lower glucose, low 
glucose DMEM (1 g/L) was supplemented 10% FBS and 2mM L-glutamine. To 
carry out the cell migration assay, MDA-MB-231 1833 cells were introduced into 
the center chamber of the microfluidic Transwell and cell culture media with 4.5 
g/L glucose or 1 g/L glucose was introduced into the quadrant chambers. After 3 
hours culture, PDMS walls were put on top of the devices, where the 3.5 mm 
holes were filled with media with 4.5 g/L glucose and the 17.5 mm hole was filled 
with same media as that in the quadrant chambers in that device.  
 
Quantifying Migration within the Microfluidic Transwell 
The media on top of the device was aspirated out and the PDMS walls were 
taken away. Cells within the devices were fixed with 4% formaldehyde solution in 
PBS for 30 minutes at room temperature. The formaldehyde solution was then 
replaced by 5 μg/ml Hoechst dye (Life Technologies) in PBS for 30 minutes at 
room temperature to stain the cell nuclei. The staining solutions were then 
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aspirated and the devices imaged by an epifluorescent microscope (Axiovert 
S100, Zeiss, Germany). Fluorescence images were taken for all quadrant 
counting chambers by a CMOS camera (Princeton Instruments, Acton, MA) using 
a 10X objective, and the number of cells in each was counted using ImageJ. Cell 
migration for each device was quantified by averaging the number of cells 
present in the four quadrant chambers. 
 
Statistical Analysis 
All conditions were tested using three different devices (n = 3). Migration data 
was analyzed by one-way ANOVA followed by multiple comparisons using Tukey 
tests in PRISM (Graphpad). Statistical significance was determined at a 
significance level of α <0.05. 
 
4.3 Results 
Cancer Cell Migration Was Inhibited by Themselves Nearby 
To test whether the direction of cancer cell migration was affected by neighboring 
cancer cells, we seeded MDA-MB-231 1833 cells in the cancer chamber and one 
of the quadrants chambers and allowed them to migration for 24 hours. The 
picture of the microfluidic Tranwell showed that MDA-MB-231 1833 cells in the 
center chamber preferentially migrated towards the empty quadrant chambers, 
where many more cells occupied the wedge-shaped microchannels that were 
connected to the empty quadrant chamber. On the other hand, even though the 
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entrance to the microchannels connected to the cell containing quadrant 
chamber was not blocked physically, few cells entered the microchannels. This 
combined evidence suggests that paracrine signals were sent and received 
between the cancer cells that were separated by the microchannels. 
 
Paracrine Signals Inhibited Cancer Cell Migration 
To confirm that the inhibition on cancer cell migration was due to the soluble 
signals secreted into the media, we performed a Transwell migration assay using 
MDA-MB-231 1833 conditioned media. The breast cancer cells were seeded in 
the center chambers with fresh cell culture media, while the quadrant chambers 
were either filled with fresh cell culture media or conditioned media. Cell 
migration from the center chamber to the quadrant chambers was significantly 
inhibited by conditioned media compared to fresh cell culture media despite the 
absence of cancer cells in the quadrant chamber. 
 
To test if the putative soluble signals were heat labile proteins, the conditioned 
media was heat-inactivated at 56°C for 30 minutes. We hypothesized that the 
heat inactivation deactivates proteins secreted by cancer cells. Cell migration 
was evaluated again within the microfluidic Transwell, where MDA-MB-231 1833 
cells were cultured in fresh cell culture media in the center chamber and 
conditioned media with or without heat inactivation was introduced into the 
quadrant chambers. From the result of this assay, we can see that heat 
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inactivating the media restored the cell migration. However, this restoration was 
not complete because cell migration was still inhibited compared to the fresh 
culture media. This set of experiments indicated that other factors might also 
inhibit cells migration.  
 
Characterizing Soluble Factors from Cancer Cells in Conditioned Media 
Attempts were made towards narrowing down the types of proteins that were 
secreted into the conditioned media. To achieve this, two types of assays were 
used. In the first assay, conditioned media was separated on a SDS-PAGE gel, 
followed by Coomassie Blue and DMB co-stain. Coomassie blue stains protein 
through interactions with the positive amine groups as well as van der Waals 
attraction. As evident in the gel, the largest band appeared to be between 52kDa 
and 76kDa, which is attributed to albumin, the major component of serum. DMB 
stains for sulfated-GAG through binding specifically to highly charged sulfated-
GAG, and appears pink. The co-stained gel showed no evident pink stains on 
any of the protein bands, which indicated little sulfated-GAG is present in the 
conditioned media or it might be below the detection limit of DMB. 
 
To detect slight changes in protein profile of the conditioned media, another SDS-
PAGE gel was stained by silver stain, which has a much higher sensitivity than 
Coomassie blue. Three types of media: fresh media, conditioned media without 
serum and conditioned media with serum were stained by silver stain. Indeed, 
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the silver stain revealed more protein bands than Coomassie blue did. The 
protein band profiles of 20 μL fresh media and 20 μL conditioned media with 
serum were compared. In Figure 4.4, the conditioned media showed more 
staining in the >225 kDa, ~52 kDa and 24–17 kDa ranges. The proteins fell into 
these ranges could potentially be the paracrine signals that cancer cells secreted 
into the media. The conditioned media without serum did not show clear bands 
except for the band that appeared between 52 kDa and 76 kDa. This band is 
very likely to be the residual albumin since before serum-free media was added 
to the dish for making conditioned media cells were cultured in media with serum. 
The silver staining results implied that potential paracrine signaling molecules 
were likely to be at a very low concentration, and thus likely potent. 
 
pH Was Not a Contribution Factor to Cell Migration 
The pH of conditioned media with serum was lower than that of cell culture 
media. So we used 1N HCl to titrate the fresh cell culture media to achieve a 
similar pH as conditioned media. This way the protein composition of the media 
would not be altered. Cell migration towards fresh media with pH of 7.4, 7 and 6 
were tested in the microfluidics Transwell. No difference in cell migration was 
observed among these pH conditions. 
 
Glucose Concentration Affected Cancer Cell Migration 
Glucose is the one of the main energy sources contained in the media. Moreover, 
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altered glucose metabolism has been studied in the context of cancer cell 
migration and invasion. To confirm that the glucose concentration in the 
conditioned media was lower than fresh cell culture media, we used a blood 
glucose meter to measure the glucose concentration in the media. Since the 
glucose concentration in the high glucose DMEM was significantly higher than 
physiological glucose level, a calibration curve for this high glucose level was 
prepared for the glucose meter. As shown in Figure 4.6, at low glucose 
concentrations, the glucose meter performed linearly; while at high glucose 
concentrations, the glucose meter started to saturate. Based on the calibration 
curve we obtained, the glucose concentration within the conditioned media with 
serum was determined to be 1.3 g/L, which showed the high glucose 
consumption of MDA-MB-231 1833 cells. 
 
Trial Fresh Media 
(mg/dL) 
Conditioned Media (60% 
Confluent) (mg/dL) 
Conditioned Media (100% 
Confluent) (mg/dL) 
1 300 211 164 
2 293 242 147 
3 289 247 162 
Table 4.1: Glucose concentration measured by blood glucose meter on three 
types of media.  
 
To alter the glucose level in cell culture media, low glucose DMEM which 
contained 1 g/L glucose was used to make up the low glucose cell culture media. 
MDA-MB-231 1833 cells were seeded in the center chamber in normal cell 
culture media and the quadrant chambers were filled with low glucose cell culture 
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media or normal cell culture media. As shown in Figure 4.7, cell migration was 
inhibited by the low glucose cell culture media. 
 
4.4 Discussion 
In this study, we demonstrated the utility of the microfluidic Transwell on studying 
the paracrine communication between cancer cells themselves and delineated 
the potential factors that constitute this communication. 
 
The microfluidic Transwell demonstrated several advantages over traditional 
cancer research platform. 
 
First, the design of multiple quadrant chambers enabled the observation of 
cancer preferential migration in one chip, where cancer cells in the center 
chamber migrated more towards empty chamber than the chamber that with 
cancer cells. This “built-in control” eliminated the possibility of artifacts or trial to 
trial variations. 
 
Compared to the tissue culture dish, the confined geometry of the microfluidic 
Transwell mimics the in vivo microenvironment better in several aspects. First, 
the confined geometry is similar to micrometastases that reside in the body, 
where they are closely surrounded by secondary host tissues. Second, the 
secreted factors will be concentrated because the high cell number to media 
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volume ratio. In tissue culture dish, the secreted factors would be more diluted 
because they diffuse into the huge pool of culture media. The micrometastases in 
the secondary site have limited diffusion because of lack of proper blood 
perfusion.  
 
The unique design of the microfluidic Transwell thus allowed us to observe 
phenomenon cannot be seen in the traditional scratch assay. The 200 μm 
microchannel created a gap between the cancer cells in the center and quadrant 
chamber, which is similar to the “gap” created by scratching the cell monolayer 
during scratch assay. However, in the scratch assay, cancer cells usually tend to 
migrate and close the gap. In the microfluidic Transwell, even though the 
microchannels were accessible to cancer cells in the center chamber, they did 
not migration into the microchannel to “cover the gap”. This difference in 
migratory behavior could partially be due to the geometry of the microchannel, 
where cells have to go through morphogenetic changes to be able to go through. 
The gap in a scratch assay does not pose these constraints to cancer cells. A 
bigger factor contributing to the difference in migratory behavior is the ability of 
the microfluidic Transwell to keep secreted factors concentrated and present their 
gradient to cells.  
 
The factors we investigated using the microfluidic Transwells are paracrine 
factors secreted by MDA-MB-231 1833 cells, pH and glucose concentration in 
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the media. 
 
That the paracrine factors secreted by cancer were proteins was confirmed by 
the heat inactivation experiment. The heat-inactivated conditioned media showed 
less inhibition on cancer migration. Further analysis on the properties of the 
proteins through Coomassie blue & dimethyl methylene blue co-stain  and silver 
staining showed that the protein was not sulfated GAG and could be of the sizes 
of >225 kDa, ~52 kDa and 24–17 kDa. Although identifying what exactly these 
proteins could be was beyond the scope of this thesis, a panel of ELISA and 
techniques such as protein mass spectrometry can be employed for this purpose. 
Based on the size of these proteins obtained through silver staining and previous 
reports on inhibition factors on cell migration, TGF-β could potentially be what is 
causing reduced cancer cell migration. Lippman et al. have shown that the MDA-
MB-231 cell line express high level of TGF-β, and the growth of several lines of 
human breast cancers are inhibited by this protein.109 Humbert et al. has reported 
that TGF-β inhibits human cutaneous melanoma cells migration and invasion 
through regulation of the plasminogen activator system.110 Another candidate 
protein is the tissue inhibitor of metalloproteinase (TIMP)-2. It has been reported 
that breast cancer secretes this protein111, and tumor cell migration can be 
blocked by TIMP-2 through alteration of metalloproteinase-metalloproteinase-
inhibitor balance.112 
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While proteins in the conditioned media had an inhibitory effect on MDA-MB-231 
1833 cell migration, other variables in the culture media was altered by the 
cancer cells. Based on our study, we showed that glucose also played a role in 
cancer cell migration. A great body of literature suggests a close relationship 
between glucose level and cancer metastasis. High glucose level activates 
pathways such as PI3K, PKCα and MLCK, which resulted in increased motility 
rates. Cancer cells usually shift their glucose metabolism from oxidative 
glycolysis to anaerobic glycolysis. The high glucose concentration in the media 
could lead to high lactate concentration. There are a number of studies reporting 
that high lactate level is associated with increased cancer migration and 
malignancy.113 
 
4.5 Conclusion 
In the study, we used the microfluidic Transwell to study the paracrine interaction 
between MDA-MB-231 1833 cells. In the “tumor microenvironment” created by 
seeding cancer cells on both sides of the microchannels, preferential migration of 
cancer cells towards empty chamber was observed. We further investigated the 
factors that dictate this preferential migration through conditioned media 
experiments and altering pH and glucose level of the culture media. We found 
that the soluble factors secreted by the cancer cells, potentially proteins, was 
responsible for inhibiting cancer cell migration. Reduced glucose also decreased 
the migration of cancer cells; however, a media pH from 6 to 7.4 did not affect 
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cancer cell migration significantly. Thus, the microfluidic Transwell demonstrated 
its unique advantage in delineating impacting factors for cancer cell migration 
research. 
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Figure 4.1: Conditioned media inhibited MDA-MB-231 1833 migration 
 
Figure 4.2: Heat-Inactivated conditioned media restored cell migration partially. 
However, control media still stimulated the most cell migration. 
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Figure 4.3: Coomassie blue and dimethylmethylene blue (DMB) co-stain of SDS-
PAGE gel loaded with fresh media and conditioned media. Three amounts of 
media was loaded for each type. Neither media was stained pink by DMB, 
indicating none or little sulfated-GAG in either media. The protein ladder marks 
225 kDa, 150 kDa, 102 kDa, 76 kDa, 52 kDa, 38 kDa, 31 kDa, 24 kDa, 17 kDa, 
and 12 kDa.  
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Figure 4.4: Upper Panel: Silver stain of SDS-PAGE gel loaded with fresh media, 
conditioned serum-free media, and conditioned media with serum. Silver stain 
revealed more bands than Coomassie blue. One major band in serum-free 
conditioned media was likely albumin, and was probably carried over during 
serum-free media conditioning. Lower Panel: The profiles of 20 μL of fresh media 
and conditioned media with serum were plotted by ImageJ and aligned together 
with regard to major peaks. The conditioned media contained more proteins 
(lower peaks) at >225 kDa, 76–52 kDa and 24–17 kDa. 
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Figure 4.5: pH did not impact MDA-MB-231 1833 migration.   
 
 
 
Figure 4.6: Calibration curve of STAT STRIP EXPRESS. Red star indicated the 
amount of glucose contained in conditioned media with serum. As glucose 
concentration increases, the output of glucose meter started to saturate. As 
indicated by the red star, the conditioned media contained similar glucose (1.8 
g/L) as low glucose DMEM. 
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Figure 4.7: MDA-MB-231 1833 cell migration within the Microfluidic Transwell 
was significantly inhibited by the low glucose.  
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Chapter 5 Future Work and Recommendations 
We demonstrated the microfabricated systems in observing insightful cancer cell 
behaviors in the context of cellular and molecular. In conjunction with new 
established molecular biology tools, we can potentially unravel the mechanism 
underlying these cancer cell behaviors. 
 
In Chapter 2, we observed the interaction between melanoma cells and 
microenvironmental cells and how different combinations of cells altered their 
interaction. To further investigate the molecular driver behind this interaction, we 
could use laser capture microdissection to selectively retrieve RNA at the 
caner/microenvironmental interface for gene expression profiling.65 The gene 
expression of cancer and microenvironmental cells within interface verse bulk 
area could be compared with a focus on genes that are known for proliferation, 
migration and ECM remodeling. 
 
In Chapter 4, we found MDA-MB-231 1833 cell migration was inhibited by the 
proteins secreted into the conditioned media. To identify this protein, a high 
throughput method should be used given the large number of proteins present in 
conditioned media. The advance in proteomics profiling technology has made it 
possible to identify specific proteins from complex sample such as tissue and 
conditioned media. A typical proteomics profiling process is depicted in Figure 
5.1. Cancer conditioned media and control media can be prepared by dialysis 
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and lyophilized to concentrate the proteins. Then the proteins can be denatured, 
reduced, alkylated and digested. The prepared proteins can then be analyzed 
through high pressure liquid chromatography followed by mass spectrometry. 
The spectrum of each sample can then be compared with spectra of known 
proteins for protein identification. Differences in protein profiles between 
conditioned media and control media are then likely to be proteins of interested, 
which in our case are the ones that inhibiting cancer cell migration. The function 
of these candidate proteins can be evaluated based on literature and irrelevant 
proteins that do not impact cell migration will be eliminated from further analysis. 
The conditioned media and control media can be analyzed by ELISA against the 
remaining protein candidates to confirm the difference in abundance. Any protein 
that is highly abundant in conditioned measured by both proteomics and ELISA 
can then be evaluated in the microfluidic Transwell to verify its migration 
inhibiting effect. 
 
Figure 5.1: Schematic outline of proteomic analysis methodology.114  
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Success in using this type of discovery flow has been reported in the context of 
cancer. Kuk et al. combined size exclusion, ultrafiltration fractionation, and 
dimensional liquid chromatography-tandem mass spectrometry to identify 
potential biomarker candidates less than 30 kDa in ascites for ovarian cancer.115 
Out of 445 proteins found in the ascites, 25 known biomarkers and 52 new 
candidate biomarkers were identified. One of these new 52 candidates, nidogen-
2, was later measured in patients’ serum through a customized ELISA, which 
confirmed its upregulation in patients with ovarian carcinoma.116 
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